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Insufficient sleep is a nearly universal problem during adolescence and is likely associated with 
various biopsychosocial and contextual factors present with this developmental period. Youth with type 1 
diabetes mellitus (T1DM) may experience greater sleep difficulties, poorer sleep quality, and greater 
daytime sleepiness/fatigue compared to healthy youth. Also, sleep difficulties are associated with poorer 
diabetes outcomes (e.g., treatment adherence). Understanding how sleep may impact illness management 
during adolescence is critical given increasing rates of non-adherence during this developmental period. 
Although research suggests poor sleep is associated with decreased neurocognitive functioning and 
increased internalizing behavior among healthy youth, limited research has examined these relationships in 
adolescents with T1DM. Further, adolescents with T1DM are at increased risk for difficulties with 
executive functioning and internalizing behaviors compared to healthy peers, and these difficulties have 
been implicated in T1DM-related outcomes. As such, the present study examined relationships among 
adolescent-reported sleep quality, quantity, and diabetes-related outcomes and the indirect effects of sleep 
quality on T1DM-related outcomes through internalizing symptoms and executive functioning.  
 
Eighty-one adolescents diagnosed with T1DM (ages 12-17) and their caregivers completed the 
study. Caregivers and adolescents completed questionnaires assessing adolescents’ executive functioning 
and adherence to diabetes management tasks. Adolescents completed additional questionnaires assessing 
sleep quality, daytime sleepiness, and internalizing symptoms. Adolescents’ medical records were reviewed 
to collect most recent hemoglobin A1c (HbA1c) values, which represent metabolic control.  
 
Results partially supported hypotheses in that poorer sleep quality, greater daytime sleepiness, and 
longer sleep duration on the weekend were associated with poorer treatment adherence, but not metabolic 
control. As predicted, sleep quality was associated with adherence through anxiety, depression, and 
executive functioning. Daytime sleepiness was associated with adherence through anxiety and had a direct 
effect on adherence independent of anxiety, depression, and executive functioning.  
 
Overall, results underscore the importance of assessing sleep quality and quantity in adolescents’ 
with T1DM. Targeting sleep as a point of intervention may help to improve adherence behaviors through 




Ashley C. Moss 
I would like to thank all those who have been pivotal to this study, as well as my academic 
endeavors over the years. First, I would like to thank the participating caregivers and adolescent, as well as 
the pediatric endocrinology staff at the Children’s Hospital of Wisconsin. A special thank you to Dr. 
Bethany Auble from the pediatric endocrinology clinic for her support throughout this study. I would also 
like to extend my appreciation to my committee members, Drs. John Grych, Nick Heck, and Jessica 
Kichler. I would especially like to express my sincerest thanks to my mentor, Dr. Astrida Kaugars. Your 
mentorship and guidance have played a critical part in helping me develop into the professional that I am 
today. I truly cannot thank you enough for everything you have done for me over the years. Thank you for 
your guidance, feedback, support, and encouragement throughout graduate school I would also like to 
thank the numerous research assistants from the Child and Family Health Lab, whose hard-work, 
dedication, curiosity, and enthusiasm helped make this project possible.  A very special thank you to my 
lab mate, Natalie Benjamin, without whose friendship and support none of this would have been possible. 
Thank you #Squad.  
I would also like to my incredible friends and family for everything you have done throughout this 
long and arduous journey. To my parents, Betsy and Ned Moss, thank you for always being my biggest 
cheerleaders and supporting me during my grand “Midwest Adventure.” I am not sure which among us is 
most thankful for my return to the Pacific Northwest! I truly could not have done this without both of you 
by my side. To my incredible significant other, Scott Schenone, thank you for believing in my dreams, 
encouraging me to pursue my passion, and taking care of me throughout graduate school. Thank you for 
being a constant source of love, support, and inspiration, and for your amazing design skills! I cannot 
fathom having successfully completed graduate school without you. I would also like to extend my 
gratitude to Dave and Lorraine Schenone for rooting for me each step of the way! I would especially like to 
thank my cohort mates, Kelly LeMaire, Stephanie Potts, Christina Figueroa, Leticia Vallejo, Kate Reiter, 
Bridget Dolan, Indrani Thiruselvam, and Natasha Najar. Your love, devotion, and passion have been an 
inspiration to me. I am honored to have been a part of such an incredible group of women. Thank you for 
your years of friendship and always being there for me throughout this process! I’ll go if you go!  
Finally, I would like to thank all my mentors and colleagues at Children’s Minnesota, and 
especially Drs. Sharon Berry, Paula Pitterle, Sherrie Kamm, Nicole Englebert, Jonny Miller, Karen Wills, 
and Mary Zielinski. I am so grateful for your enthusiasm, interest, and support in completing this project. 
Thank you for the exceptional training and many opportunities with which you have provided! Thank you 
to my internship cohort-mate, Amanda Lossia, who helped keep me sane, fed, and on-task!   










TABLE OF CONTENTS 
ACKNOWLEDGEMENTS………………………………………………………………………………..…i  
LIST OF TABLES…………………………………………………………………………………………..iv 




B. Type 1 Diabetes Mellitus…………………………………………………………….11 
C. Sleep in Youth with T1DM………………………………………………………….15  
D. Present Study………………………………………………………………………...41  
E. Hypotheses…………………………………………………………………………..43 





A. Data Analytic Plan…………………………………………………………………...52 
B. Descriptive Analyses………………………………………………………………...57 
C. Preliminary Analyses………………………………………………………………..64 
D. Hypotheses 1-4: Associations Among Adolescent-Reported Sleep Quality, Sleep 
Quantity, and Adolescent- and Caregiver-Reported Adherence to Diabetes  
Regimen and Metabolic Control…………………………………………………….66 
 
E. Hypotheses 5-8: Mediation of Aspects of Sleep and T1DM-Related Outcomes by 
Internalizing Symptoms and Neurocognitive Functioning………………………….68 
 
F. Hypotheses 9-12: Mediation of Sleep Quantity and T1DM-Related Outcomes by 
Internalizing Symptoms and Neurocognitive Functioning………………………….77 
 
G. Exploratory Analyses………………………………………………………………..82 
IV. DISCUSSION……………………………………………………………………………….…….88 




B. Mediations Models Predicting Treatment Adherence ……………………………....92 
C. Exploratory Analyses………………………………………………………………..96 
D. Sleep Quantity in Adolescents with T1DM ………………………………………...96 
E. Sleep Quality in Adolescents with T1DM…………………………………………..98 
F. Adherence and Metabolic Control…………………………………………………..98 
G. Clinical Implications………………………………………………………………...99 







LIST OF TABLES 
Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive 
 Functioning, and T1DM-Related Outcomes in Youth with T1DM……………………………….27 
 
Table 2. Constructs and Measures Included in the Present Study…………………………………………..47  
 
Table 3. Primary Caregiver Demographic and Household Characteristics (N = 81)……………………….58 
 
Table 4. Adolescent Demographic Characteristics (N = 81)………………………………………………..59 
 
Table 5. Means, Standard Deviations, and Ranges for Adolescent- and Caregiver-Report  
Measures (N = 81)………………………………………………………………………………….61 
 
Table 6. Sleep Quantity Based on Five Night Sleep Diary (N = 51)………………………………………..62 
 
Table 7. Percentage of Adolescents Obtaining Less Than 8 Hours of Sleep (N = 51)……………………...63 
 
Table 8. Pearson Correlations of Adolescent Age and Total Sleep Time  
Variables (N = 51)…………………………………………………………………………………65 
 
Table 9. Pearson Correlations of Adolescent-Report Measures of Sleep Quality 
and Quantity (N = 51)……………………………………………………………………………...67 
 
Table 10. Pearson Correlations of Adolescent-Report Measures of Sleep Quality,  
Adherence, and Metabolic Control (N = 81)………………………………………………………69 
 
Table 11. Pearson Correlations of Sleep Quantity, Adherence, and Metabolic 
Control (N = 51)…………………………………………………………………………………...70 
 
Table 12. Regression Coefficients, Standard Errors, and Model Summary Information for 
the Sleep Quality Parallel Multiple Mediation Model Depicted in Figure 6……………………....72 
 
Table 13. Regression Coefficients, Standard Errors, and Model Summary Information for 
the Daytime Sleepiness Parallel Multiple Mediation Model Depicted in Figure 7………………..75 
 
Table 14. Simple Mediation Model for Adolescent-Reported Sleep Quality Predicting  
Caregiver-Reported Adherence, Through Caregiver-Reported Executive  
Functioning, Depicted in Figure 8…………………………………………………………………78 
 
Table 15. Simple Mediation Model for Adolescent-Reported Daytime Sleepiness Predicting  
Caregiver-Reported Adherence, Caregiver-Reported Executive Functioning,  
Depicted in Figure 9……………………………………………………………………………….80 
 
Table 16. Regression Coefficients, Standard Errors, and Model Summary Information for  
the Exploratory Anxiety Parallel Multiple Mediation Model Depicted  
in Figure 10………………………………………………………………………………………...83 
 
Table 17. Regression Coefficients, Standard Errors, and Model Summary Information for 
the Exploratory Depression Parallel Multiple Mediation Model Depicted  




LIST OF FIGURES 
Figure 1. Biopsychosocial and contextual model of sleep in adolescence  
(Becker, Langberg, & Byars, 2015)………………………………………………………………....7  
 
Figure 2. Hypothetical model of the impact of type 1 diabetes mellitus on sleep 
(Barone & Menna-Barreto, 2011)………………………………………………………………….17 
 
Figure 3. Proposed model examining the relationships among aspects of sleep and T1DM-related 
outcomes through internalizing symptoms and executive functioning…………………………….26 
 
Figure 4. Conceptual model for simple mediation. X = Independent Variable, M = Mediator, Y = 
Dependent Variable, a path = effect of X on M, b path = effect of M on Y, while  
holding X constant, ab = indirect effect of X on Y through M, c’ = estimates  
the direct effect of X on Y holding M constant, c = total effect of X on Y,  
in other words c’ + ab……………………………………………………………………………...53 
 
Figure 5. Conceptual model for parallel multiple mediation. X = Independent Variable, M = Mediator,  
Y = Dependent Variable, a path = effect of X on M, b path = effect of M on Y, while  
holding X constant, ab = indirect effect of X on Y through M, c’ = estimates  
the direct effect of X on Y holding M constant, c = total effect of X on Y, 
in other words c’ + ab……………………………………………………………………………....55 
 
Figure 6. Parallel multiple mediation model examining the relationship between adolescent-reported  
sleep quality and adherence through anxiety, depression, and executive functioning (GEC)……..73 
 
Figure 7. Parallel multiple mediation model examining the relationship between adolescent-reported 
daytime sleepiness and adherence through anxiety, depression, and executive 
functioning (GEC)……………………………………………………………………………….....76 
 
Figure 8. Simple mediation model examining the relationship between adolescent-reported sleep quality 
and caregiver-reported adherence through caregiver-reported 
executive functioning (GEC)……………………………………………………………………....79 
 
Figure 9. Simple mediation model examining the relationship between adolescent-reported daytime 
sleepiness and caregiver-reported adherence through caregiver-reported 
executive functioning (GEC)…………………………………………………………………….....81 
 
Figure 10. Parallel multiple mediation model examining the relationship between adolescent-reported  
anxiety and adherence through sleep quality and daytime sleepiness……………………………..84 
 
Figure 11. Parallel multiple mediation model examining the relationship between adolescent-reported 








 Insufficient sleep is a nearly ubiquitous problem during adolescence. A recent population-based 
survey found that nearly 69% of adolescents in the United States sleep less than 8 hours on school nights 
(Eaton et al., 2010). Various biopsychosocial and contextual factors appear to converge during adolescence 
and may account for the pervasive nature of insufficient sleep commonly observed during this stage of 
development (Becker, Langberg, & Byars, 2015; Carskadon, 2011; LeBourgeois, Giannotti, Cortesi, 
Wolfson, & Harsch, 2005). Although a substantial amount of research has demonstrated that most 
adolescents do not sleep the recommended amount (i.e., eight hours), a paucity of research has considered 
sleep within the context of type 1 diabetes mellitus (T1DM). Although this area of research is in its infancy, 
numerous studies have shown that youth1 with T1DM experience greater sleep difficulties, poorer sleep 
quality, and greater daytime sleepiness/fatigue compared to healthy youth (Blanz, Rensch-Reimann, Fritz-
Sigmund, & Schmidt, 1993; Caruso et al., 2014; Matyka, Crawford, Wiggs, Dunger, & Stores, 2000; 
Perfect et al., 2012; Pillar et al., 2003; Varni, Limbers, Bryant, & Wilson, 2009; Villa et al., 2000; 
Yeshayahu & Mahmud, 2010). Underlying bioregulatory processes such as hypoglycemia, poor glycemic 
control, and rapid glycemic change appear to be associated with poor sleep in youth with T1DM (Caruso et 
al., 2014; Matyka et al., 2000; Perfect et al., 2012; Perfect, 2014; Pillar et al., 2003; Porter Gyrne, Stick, & 
Jones, 1996; Yeshayahu & Mahmud, 2010). Additionally, illness-related sequelae, such as stress associated 
with managing a chronic illness, may differentially impact sleep in youth with T1DM (Perfect, Elkins, 
Lyle-Lahroud, & Posey, 2010). Difficulties with sleep may further impact self-regulatory skills, such as 
regulating cognitions, emotions, and behaviors associated with diabetes management that support 
adherence and glycemic control (Turner, Queen, Butner, Wiebe, & Berg, 2016). Therefore, adolescents 
with T1DM may be at particular risk for difficulties with sleep due to a combination of biospsychosocial 
and illness-related factors. Although research examining the relationship between sleep and illness 
management in individuals with T1DM is in its infancy, the American Diabetes Association (2017) has 
recommended providers assess sleep patterns and sleep duration as a part of regular comprehensive medical 
evaluations. Recently, researchers have started to focus their efforts on developing clinically relevant sleep 
interventions for youth with T1DM (Perfect et al., 2016).  
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 Understanding how sleep may impact adherence to diabetes management tasks during adolescence 
is clinically relevant, as rates of non-adherence have been found to increase substantially during this 
developmental stage (Kichler, Moss, & Kaugars, 2012; Weissberg-Benchel et al., 1995). Initial research 
suggests sleep difficulties are associated with poorer diabetes outcomes, such as adherence (Hazen et al., 
2015; McDonough, Clements, DeLurgio, & Patton, 2017). Research regarding the relationship between 
sleep difficulties and glycemic control in youth with T1DM is equivocal (Adler, Gavan, Tauman, Phillip, & 
Shalitin, 2016; Blanz et al., 1993; Caruso et al., 2014; Happe et al., 2005; Jaser & Ellis, 2016; Perfect et al., 
2012; Perfect, 2014; Villa et al., 2000, Yeshayahu & Mahmud, 2010).  Research suggests that 
neurocognitive functioning and internalizing behavior, such as anxiety and depression, may be 
compromised by poor sleep among healthy youth (Beebe, 2011; Moore et al., 2009; Moore & Meltzer 
2008; Sarchiapone et al., 2014). Limited research examining these associations among youth with T1DM 
suggests poorer sleep quality and daytime sleepiness are associated with increased symptoms of depression 
(Adler et al., 2016; Hazen et al., 2015; Perfect et al., 2012) and poorer executive functioning among youth 
with T1DM (Caruso et al., 2014).  
 The relationship between sleep, neurocognitive functioning, and internalizing behavior may be 
particularly relevant to youth with T1DM as they may be at increased risk for experiencing neurocognitive 
deficits (Caruso et al. 2014; Desrocher & Rovet 2004; Gaudieri, Chen, Greer, & Holmes, 2008; Northam, 
Rankins, & Cameron, 2006) and greater internalizing symptoms (Kovacs, Goldston, Obrosky, & Bonar, 
1997; Northam, Matthews, Anderson, Cameron, & Werther, 2004) compared to their otherwise healthy 
peers. Internalizing symptoms and neurocognitive deficits have been implicated in illness management and 
T1DM outcomes (Bagner, Williams, Geffken, Silverstein, & Storch, 2007; Bernstein, Stockwell, Gallagher, 
Perez et al., 2017; Rosenthal, & Soren, 2013; Johnson, Eider, Young, Brierley, & Heller, 2013; Lawrence 
et al., 2005; Whittemore et al., 2002). As such, there is a need to understand how internalizing behaviors 
and neurocognitive functioning may influence the relationship between sleep and illness management and 
outcomes in youth with T1DM.   
Sleep 
Definition of Sleep 
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 Sleep is a universal (Pace-Schott & Hobson, 2002) and dynamic (Pallayova, Donic, Gresova, 
Peregrim, & Tomori, 2010) process characterized by a heightened threshold for sensory input, attenuation 
of motor output, changes in central and peripheral physiology, and a diminished level of conscious 
awareness (Pace-Schott, 2010). Although sleep comprises approximately 1/3 of our lives (Sejnowski & 
Destexhe, 2000), the purpose of sleep in humans is not well understood (Frank, 2006). 
 Sleep appears to be vital for both physical and mental health, as well as performance and safety 
(Czeisler, 2015). While there is no unifying theory, sleep is generally hypothesized to allow for the body 
and mind to rest while various processes take place (National Sleep Foundation [NSF], 2006) such as the 
reorganization and consolidation of memory, the rehearsal of new learning or genetically programmed 
behaviors, and the generation of immobility at times when activity would otherwise be dangerous and/or 
waste energy resources (Bryant, Trinder, & Curtis, 2004).   
Measurement of Sleep 
 Objective measures of sleep. 
 Polysomnography. While there are numerous objective and subjective measures available to 
examine sleep, polysomnography (PSG) is considered the gold standard for objective assessment of sleep 
(Buckhalt, Wolfson, & El-Sheikh, 2009; Collop, 2006). Polysomnography typically involves the 
monitoring and transduction of various physiological signals including EEG and may involve 
electromyography (nerve and muscle functioning), electrocardiogram (heart), electrooculography (leads 
placed above eyes), respiration using nasal thermistor or nasal cannula pressure transducer, pulse, 
respiratory effort, and oxygen saturation (Collop, 2006). Although PSG is considered the gold standard for 
measuring sleep, it is expensive and requires specialty-trained personnel to score and interpret complex 
output (Buckhalt et al., 2009). Conducting PSG with children may pose particular methodological 
challenges as PSG is frequently conducted in an unfamiliar laboratory setting, which may directly affect 
children’s sleep. Furthermore, parents may be hesitant to leave children in an unfamiliar setting with 
unfamiliar adults (Beebe et al., 2008; Fallone, Seifer, Acebo, & Carskadon, 2002). Changes in respiratory 
rates and patterns across development act to further compound aforementioned methodological challenges 
in conducting pediatric PSG. As developmental changes are associated with variable presentations and 
4 
etiologies of sleep-related disorders in children as compared to adults, it is not appropriate to evaluate 
pediatric PSG against adult PSG norms; however, the interpretation of pediatric PSG may be particularly 
difficult as there is limited normative data available for interpretation purposes (Griebel & Moyer, 2006).  
 Actigraphy. An alternative objective measure of sleep that may be appropriate to use with 
pediatric populations is actigraphy. An actigraph is a small, relatively unobtrusive watch-like device worn 
on the non-dominant wrist that allows for recording and storage of data generated by daytime and nighttime 
movements over the course of days, weeks, or longer (Acebo, 2006). Actigraphy has a distinct advantage 
over PSG as it allows for non-invasive measurement of sleep-wake patterns in a child’s natural 
environment and has been effectively used in research with children and adolescents ages 0-18 years 
(Meltzer, Montgomery-Downs, Insana, & Walsh, 2012). 
 Despite its advantages, actigraphy is not without its limitations. In a review of validation studies, 
Meltzer and colleagues (2012) found that research uniformly shows that actigraphy has high sensitivity but 
low specificity across all age ranges (i.e., infants through adolescents). That is, while actigraphy appears to 
reliably identify sleep similar to that of other objective measures of sleep, it appears to have limited ability 
to accurately detect wake after sleep onset in pediatric populations (Meltzer et al., 2012), particularly 
during times of transition between wake and sleep (Acebo, 2006). For example, Johnson and colleagues 
(2007) found that actigraphy underestimated sleep compared to PSG in 181 adolescents due to 
overestimation of the amount of time spent awake after sleep onset. That is, actigraphy may be 
oversensitive to and code nocturnal movement as awake rather than asleep. As a result, actigraphy tends to 
underestimate total sleep time (Johnson et al., 2007) in pediatric populations. Although actigraphy has 
become an increasingly popular objective measure of sleep in pediatric populations, there are no current 
practice standards regarding recording parameters and scoring of actigraph signals in children and 
adolescents. Meltzer and colleagues (2012) note that no specific normative data is available for interpreting 
actigraphy in pediatric populations. Furthermore, limited research has considered the impact of rapid 
changes in sleep across development on scoring thresholds for actigraphy.  
 Subjective measures of sleep. 
 Sleep diary. Sleep may also be measured using various subjective methods, including sleep 
diaries. Although sleep diaries may be used in conjunction with actigraphy, they are often used as stand-
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alone measures and are considered the gold standard for the subjective measurement of sleep (Carney et al., 
2012). Sleep diaries typically involve self- or other-monitoring of various metrics of sleep, including, but 
not limited to, sleep onset latency (i.e., the time it takes to fall asleep), wake after sleep onset (i.e., arousals 
from sleep), total sleep time, total time spent in bed, sleep efficiency (i.e., percentage of time asleep out of 
total amount of time in bed), and perceived sleep quality (Tremaine, Dorrian, & Blunden, 2010). Sleep 
diaries are typically completed in the evening before going to bed and in the morning upon waking and 
allow for the quantitative measurement of various aspects of sleep across multiple days. Sleep diaries may 
be more reliable that other subjective report measures of sleep because they rely on immediate recall of 
information, rather than retrospective memory (Wolfson et al., 2003).  
 Sleep diaries also have numerous limitations. First, individuals tend to overestimate sleep latency 
(i.e., time it takes to fall asleep; Acebo, 2006; Chambers, 1994), underestimate total amount of time spent 
asleep, and are not always aware of nocturnal waking events (Chambers, 1994; Short, Gradisar, Lack, 
Wright, & Carskadon, 2012). Use of parental report of child/adolescent sleep using sleep diary may have 
limited reliability as parental knowledge about their children’s sleep is often restricted and biased (Sadeh, 
1996). Despite their widespread use, there is relatively little research comparing sleep diaries to other 
objective measures of sleep, like PSG, in non-sleep-disordered populations of children and adolescents 
(Tremaine et al., 2010).   
 Self- and other-report questionnaires. Numerous self- and other-report (primarily 
parent/caregiver) measures have been developed to capture the multidimensional nature of sleep. Youth- 
and caregiver-report sleep questionnaires are a critical component of assessing sleep as these measures may 
provide unique insight into youth’s sleep quality. Questionnaires are primarily retrospective in nature and 
tend to focus on assessing typical sleep patterns, sleep disturbances, or sleep-related behavior (e.g., sleep 
habits/hygiene, sleep quality) over a specific period of time (Lewandowski, Toliver-Sokol, & Palermo, 
2011). Subjective report measures are easy to use (Wolfson et al., 2003), are cost effective, and require less 
time to complete as compared to objective measures of sleep; however, sleep questionnaires have their 
limitations.  
 First, subjective questionnaires tend to be retrospective in nature and are therefore highly 
dependent upon the respondent’s memory of past events. As such, the accuracy and reliability of self- or 
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other-reports of sleep may be limited compared to sleep diaries or other objective measures of sleep 
(Wolfson et al., 2003). Wolfson and colleagues (2003) suggest that adolescents may report most recent, 
salient, and/or most socially desirable responses, rather than the most accurate information. Additionally, 
questionnaires often rely on parental reports and may be problematic as parents may be unable to 
accurately report on their child’s sleep, especially night awakenings, and the time it takes their child to fall 
asleep at night (Sadeh, 1996; Werner, Molinari, Guyer, & Jenni, 2008). Additionally, parental reports of 
sleep quality and daytime sleepiness are based on observations and may not accurately reflect their child’s 
subjective experience. It is unclear when children and adolescents become more accurate reporters of their 
own sleep than their parents.  
 In summary, objective measures of sleep are the preferred method for quantifying sleep and 
examining sleep architecture in children and adolescents, although caution may be warranted given the lack 
of developmentally-appropriate norms for pediatric populations. Among subjective report measures, sleep 
diaries are considered the gold standard for quantifying sleep in children and adolescents. Self- and other-
report questionnaires provide a unique opportunity to examine subjective perceptions of sleep quality and 
other behaviors that alternative measures may not provide.  
Insufficient Sleep During Adolescence 
 Age is the most significant factor known to impact both sleep architecture and quality of sleep 
(Rosenthal, 2006). While it is recommended that school aged children (ages 6-13) obtain 9 to 11 hours of 
sleep and adolescents (ages 14-17) obtain 8-10 hours of sleep per night (Hirshkowitz et al., 2015), research 
suggests that the majority of adolescents sleep less than the recommended amount. In a nationally 
representative survey of 14,041 high school students, Eaton and colleagues (2010) found that nearly 69% of 
adolescents reported sleeping less than 8 hours on school nights. Additionally, research consistently shows 
increasing rates of insufficient sleep across adolescence (i.e., total sleep time decreases with age; Eaton et 
al., 2010; NSF, 2006; NSF, 2014) despite the fact that adolescents’ need for sleep does not decrease 
compared to preadolescence (Carskadon, Wolfson, Acebo, Tzischinsky, & Seifer, 1998; Carskadon et al., 
1980). Biopsychosocial and contextual factors may account for the pervasive nature of insufficient and 
irregular sleep observed during adolescence (see Figure 1; Becker et al., 2015; Carskadon, 2011; 










Biological factors. Biologically, the transition from childhood to adolescence (i.e., puberty) is 
associated with various neurodevelopmental changes that may impact sleep onset and architecture. 
Research suggests that neurodevelopmental changes are associated with circadian phase delay (Process C; 
Carskadon, 2011) and slowed accumulation of homeostatic sleep pressure (Process S; Becker et al., 2015). 
These neurodevelopmental changes translate to the preference for later sleep onset, and therefore later 
bedtime, during adolescence (Giannotti, Cortesi, Sebastiani, & Ottaviono, 2002) and a bioregulatory driven 
delay in sleep onset during adolescence (Carskadon, 2011).  
Psychosocial factors.  
 Bedtime. In addition to biological changes that occur during this stage of development, 
adolescents are confronted with various psychosocial pressures, expectations, and responsibilities that may 
impact their sleep. As adolescence is a developmental period often characterized by increasing levels of 
independence and autonomy, one psychosocial factor that may be implicated in the pattern of inadequate 
sleep during adolescence is increased bedtime autonomy (Carksadon, 2011). Parent-determined bedtime 
has been found to have a positive effect on adolescent sleep, including earlier bedtime, more sleep, and less 
daytime fatigue as compared to adolescents who set their own bedtimes. Despite the benefits associated 
with parental-set bedtime, parent-determined adolescent bedtime steadily decreases with age across 
adolescence (Short et al., 2011). As a result, adolescents whose parents do not set their bedtimes tend to go 
to bed later and sleep less than their peers whose parents continue to set their bedtimes (Short et al., 2011).  
 Electronic media use. Another psychosocial factor that may negatively impact adolescent sleep is 
the use of electronic devices at night (e.g., cell phones, computers/laptops, tablets, televisions, electronics, 
video games, music devices). The NSF Sleep in America Poll: Sleep in the Modern Family (2014) reported 
that approximately 72% of children have at least one and 51% have at least two or more electronic devices 
in their rooms. Of note, the number of electronics present in a child’s room appears to increase as a 
function of age; while 72% of all children ages 6 – 17 have at least one electronic device in their rooms, 
that percentage increases to nearly 90% among adolescents ages 15-17.  
 Although it is increasingly common to find electronic devices in the rooms of adolescents, 
particularly older adolescents, research suggests that their use may have a direct negative effect on sleep. In 
a comprehensive review of the impact of electronic media use on sleep of children and adolescents, Cain 
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and Gradisar (2010) found that children and adolescents who use electronic devices before bedtime 
experience shorter, later, and/or more disrupted sleep as well as poorer daytime functioning (e.g., daytime 
sleepiness and disruptive behavior) compared to children and adolescents who do not use electronic 
devices. Use of electronic devices before bed may make it more difficult for adolescents to sleep as 
electronic device use may increase arousal (Cain & Gradiser, 2010; Carskadon, 2011). Furthermore, 
exposure to bright light, particularly from televisions or computer screens, may suppress the release of 
melatonin and consequently delay circadian rhythms and sleep onset (Higuchi, Motohashi, Liu, & Maeda, 
2005).  
 School start time. School start time in the US is a well-recognized and important contextual factor 
when considering sleep in adolescence (Kirby, Maggi, & D’Angiulli, 2011), as early school start times may 
place strict limitations on adolescents’ ability to meet their sleep needs (Carskadon, 2011). A policy 
statement released by the American Academy of Pediatrics (2014) recommended that school start times be 
delayed until 8:30 am or later for both middle and high school. Research among adolescents in the United 
States has unequivocally shown that early school start times are associated with adolescents obtaining less 
sleep and experiencing increased levels of fatigue and daytime sleepiness (Danner & Phillips, 2008; 
Dexter, Bijwadia, Schilling, & Applebaugh, 2003; Owens, Belon, & Moss, 2010). In a study examining the 
effect of school start time on adolescent sleep, Dexter and colleagues (2003) showed that adolescents in 
10th and 11th grade who had an earlier school start time (7:50 am) reported receiving significantly less sleep 
and experienced significantly more daytime sleepiness than adolescents whose school start time was 45 
minutes later. In one college preparatory school it was found that delaying school start time by 30 minutes 
had a significant positive impact on the percent of adolescents who were able to obtain eight hours of sleep 
per night (Owens et al., 2010). Similarly, Danner and Phillips (2008) examined the impact on adolescents’ 
sleep of a large school district in Kentucky delaying their school-start times by one hour. As expected, 
duration of sleep increased during the school year following the change in school start time and the 
percentage of adolescents reporting sleeping eight or more hours per night increased from 35.7% to 50%. 
 Other psychosocial factors. Other psychosocial factors that may indirectly impact sleep during 
adolescence include increased academic pressure/workload and involvement in extra-curricular 
activities/work. Specifically, the amount of time spent studying outside of school has been found to be 
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associated with incidence and persistence of restricted sleep (i.e., sleeping six hours or less) among 
adolescents (Roberts, Roberts, & Xing, 2011). Further, time spent completing homework may increase 
adolescents’ stress (Kouzma & Kennedy, 2002) and anxiety, which may further impact sleep onset (Becker 
et al., 2015) through increased activation of the HPA axis and subsequent physiological arousal due to the 
release of cortisol. Working a part-time job and engaging in extracurricular activities may also negatively 
impact sleep quality/duration during adolescence (Roberts et al., 2011; Safron, Schulenberg, & Bachman, 
2001; Vinha, Cavalcante, & Andrade, 2002) because these activities may limit the amount of time available 
for adolescents to sleep (Vinha et al., 2002). 
 Research has shown that insufficient sleep is a nearly ubiquitous problem among adolescents in 
the U.S. The convergence of various biological, psychosocial, and sociocultural factors during adolescence 
are thought to result in adolescents’ tendency to initiate sleep later, awaken earlier, and sleep for shorter 
periods of time (Becker et al., 2015; Carskadon, 2011). Pubertal changes, including a delay in circadian 
rhythm and slowed accumulation of sleep pressure, result in delayed sleep onset (Carskadon, 2011). These 
bioregulatory changes are compounded by increased bedtime autonomy, academic pressure, technology use 
at bedtime/in the bedroom, and early school start times (Carskadon, 2011). While bioregulatory 
mechanisms appear to cause sleep onset delay, psychosocial factors maintain and promote shorter sleep 
times during adolescence. Taken together, these biopsychosocial factors contribute to a set of well-
recognized problems including late nights, erratic sleep/wake schedules, and insufficient sleep on school 
nights (Holm et al., 2009). 
 Although sleep is negatively affected by the convergence of various biopsychosocial factors 
during adolescence, sleep in children and adolescents with chronic illness may be further compromised by 
disease processes, as well as illness-related sequela.  
Sleep in Pediatric Chronic Illness 
 While sleep difficulties are nearly ubiquitous during adolescence, research suggests that sleep-
wake disturbances are especially prevalent among children and adolescents with acute and chronic illnesses 
(Hysing, Sivertsen, Stormark, Elgen, & Lundervold, 2009; Long, Krishnamurthy, & Palermo, 2008; 
Meltzer, Ullrich, & Szefler, 2014; Pasarelli et al., 2006; Yuksel et al., 2007). For example, research 
suggests that youth with T1DM experience greater sleep difficulties than healthy youth (Blanz et al., 1993; 
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Matyka et al., 2000; Monaghan, Herbert, Cogen, & Streisand, 2012; Perfect et al., 2012). Underlying 
disease processes and illness-related sequelae, such as medication use, hospitalization, stress associated 
with illness management, and mental health functioning, likely account for at least some sleep difficulties 
commonly observed in youth with chronic illness (Lewandowski, Ward, & Palermo, 2011; Lewin & Dahl, 
1999). Sleep difficulties may be particularly concerning for youth with chronic illness as poor sleep may 
exacerbate underlying health difficulties, which may disrupt sleep even further (Amin, Bean, Burklow, & 
Jeffries, 2005; Hanson & Chen, 2008; Lewandowski et al., 2011; Parisi et al., 2010).  
Type 1 Diabetes Mellitus 
 Type 1 diabetes mellitus is the second most prevalent chronic illness in children and adolescents 
after asthma, and T1DM is estimated to impact 1 in 300 children before the age of 18 (Maahs, West, 
Lawrence, & Mayer-Davies, 2010) and is most often diagnosed in children between the ages of 9 and 15 
(Watkins, Drury, & Howell, 1996). T1DM is an autoimmune disease that is genetically mediated and 
involves impaired glucose metabolism due to insulin deficiency secondary to the destruction of beta cells of 
the pancreas, which are responsible for the production of insulin (Brannon, Feist, & Updegraff, 2014; 
Shrestha, 2010; Wysocki, Buckloh, & Greco, 2009). This deficiency results in an increase in glucose in the 
bloodstream, which damages other body systems such as blood vessels and nerves (Shrestha, 2010). T1DM 
is associated with various short- and long-term health consequences. In the short term, T1DM is associated 
with increased risk for hypoglycemia (i.e., dangerously low levels of blood glucose in the body), which is 
often accompanied by feelings of weakness, nervousness, sweatiness, blurred vision, headache, and 
changes in mood. T1DM is also associated with increased risk for hyperglycemia (i.e., extremely high 
levels of blood glucose), which may lead to diabetic ketoacidosis (i.e., a condition in which the body begins 
to breakdown fatty acids in the liver resulting in a secretion of ketones into the bloodstream, thus increasing 
the acidity of the blood; Beaser, 2007), loss of consciousness, coma, or even death (Wysocki et al., 2009). 
In the long term, poorly controlled T1DM can lead to various micro- and macrovascular complications 
(Maahs et al., 2010; Wysocki et al., 2009) such as stroke, heart attack/heart disease, circulatory disorders, 
amputation, kidney disease, nerve damage, and retinopathy (Wysocki et al., 2009). 
Diabetes Management and Adherence 
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 Diabetes management requires adherence to a complex medical regimen including administering 
several daily insulin injections, self-monitoring of blood glucose, monitoring carbohydrate intake, and 
engaging in daily exercise (Wysocki et al., 2009). Research suggests that youth with T1DM, especially 
older adolescents (Kovacs, Goldston, Obrosky, & Iyengar, 1992), experience difficulties with adherence 
(Kichler et al., 2012). Additionally, Weissberg-Benchel and colleagues (1995) found that adolescents with 
T1DM displayed high levels of diabetes mismanagement, particularly with regard to missing blood glucose 
checks and insulin injections.  
 Numerous methods and psychometrically sound measures are available for assessing adherence 
among individuals with T1DM, including self- and other-report measures (e.g., Self-Care Inventory 
Revised, SCI-R; Weinger, Butler, Welch, & La Greca, 2005), diary/interview measures (e.g., 24-hour recall 
interview; Johnson, Silverstein, Rosenbloom, Carter, & Cunningham, 1986), electronic monitoring (e.g., 
blood glucose checks/meter downloads; Quittner, Modi, Lemanek, Ievers-Landis, & Rapoff, 2008), and 
provider reports (e.g. estimates of blood glucose testing frequency; Kichler, Kaugars, Maglio, & 
Alemzadeh, 2012).  
 Methodological challenges. There are a number of unique challenges associated with the 
measurement of adherence in children and adolescents with chronic illness. First, measures of adherence 
often use variable time frames (e.g., previous 24 hours, previous two weeks, or one to three months) 
making it difficult to compare, at least directly, and synthesize data across measures. Another major 
challenge in measuring adherence is that advancement in medical treatments typically outpaces the ability 
to develop valid and reliable measures of adherence, which may render previous measures obsolete. As 
multiple reporters are often used in pediatric research (e.g., child and/or caregiver), it is often unclear 
whose responses are most accurate and reliable. Finally, rapidly changing medical treatments/prescriptions 
make it difficult to track specific adherence behaviors (Quittner et al., 2008).  
 Subjective reports. Adherence is frequently measured using subjective self- or other-reports with 
questionnaires or through the use of interviews. Subjective report measures have numerous strengths; they 
are inexpensive, often comprehensive in nature, and allow for collection of information from multiple 
informants (e.g., patient, caregiver, health care providers, teachers, etc.). Additionally, structured/semi-
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structured interviews allow for follow-up questions, which may provide additional important information 
regarding patient or others’ perceptions regarding medical regimen and barriers to adherence.   
 Subjective reports are, however, not without their limitations. Weaknesses of subjective report 
measures include the tendency to overestimate adherence to medical regimen; variable reliability of 
participant recall due to dependence on respondent’s memory; tendency to assess more global beliefs about 
behavior rather than frequency of specific behavior; assessment of only one person’s perspective; and 
difficulties associated with administering self-report measures to children eight years of age or below 
(Quittner et al., 2008).  
 Daily diary/interview methods. Daily diary methods, such as a 24-hour recall interview (Johnson 
et al., 1986), are typically conducted over the phone and have several advantages over self- or other-report 
measures. First, these types of measures are typically conducted in real time or after a short period of time 
has passed since the behavior has been performed (e.g., previous 24 hours). Additionally, because of the 
shortened time frame, daily diary measures are better able to assess specific behaviors that have recently 
occurred, rather than global perspective of behavior. As daily diary methods are time limited in nature, they 
also tend to facilitate the identification of various barriers to adherence. Finally, daily diary measures tend 
to be unobtrusive in nature as patients and their families are typically unaware that activities associated 
with their medical treatment are the focus of assessment (Modi & Quittner, 2006).  
 While daily diary methods have their advantages over other subjective report measures, there are 
numerous limitations. Daily diary measures require a greater time commitment from both reporters and 
individuals administering these types of measures compared to subjective reports, and they typically 
require specialized training. Additionally, scheduling phone calls can be difficult as some families do not 
have regular access to a phone, do not answer calls, or have limited availability to speak on the phone. 
Finally, diary measures often produce complicated data sets that require complex analytical approaches 
(Larson & Delespaul, 1992; Modi & Quittner, 2006).      
 Electronic monitoring. Technological advances have allowed for the development of automated 
measures of adherence (Quittner et al., 2008), such as glucometers, which are used to regularly monitor 
blood glucose levels in individuals with diabetes. Electronic monitors can store real-time information 
ranging from several months to three years, and data can be easily downloaded for analysis by users or 
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medical providers. Electronic monitoring has the distinct advantage of being able to provide real-time, 
continuous, and long-term measurement of an adherence behavior and can be used to determine non-
adherence to blood glucose monitoring (Quittner et al., 2008). A major disadvantage of electronic 
monitoring systems is that they may malfunction (Quittner et al., 2008). Additionally, electronic monitors 
such as glucometers do not provide information regarding other adherence behaviors such as taking the 
correct dose of insulin at the right time, consuming the correct proportion of food, or accurately counting 
carbohydrates. Despite its limitations, electronic monitoring is considered more accurate than other 
measures of adherence because monitors are more “objective” in nature and often reveal poorer adherence 
when compared to self- or other-reports (Riekert & Rand, 2002).  
 Provider report. Provider reports of adherence may be made based on clinical impressions of 
frequency of daily blood glucose checks (Kichler et al., 2012). Although research has demonstrated 
provider reports are associated with average daily blood glucose checks in adolescents with T1DM (Kichler 
et al., 2012), provider reports are often unreliable (Johnson, 1992). Specifically, providers are often aware 
of patient’s health status (e.g., metabolic control), which may skew their ratings of adherence. Furthermore, 
provider ratings of patient adherence are often global in nature as patients are often rated as adherent or 
non-adherence. Finally, global ratings of adherence, such as provider reports, are unable to capture the 
complexity of adherence to diabetes management tasks (Johnson, 1992).  
 Although self- or other-report measures, diary/interview measures, and electronic monitoring are 
considered valid and reliable approaches to measuring adherence in children and adolescents with T1DM, 
Quittner and colleagues (2008) recommend using at least two different forms of measurement when 
examining adherence in children and adolescents with chronic illness. As a review of adherence measures 
is beyond the scope of this paper, the interested reader is encouraged to read Quittner et al. (2008) for a 
thorough review of various adherence measures commonly used in pediatric psychology. 
Metabolic Control 
 Hemoglobin A1C (HbA1c) is a biological blood assay that is used as an objective measure of 
average glycemic control during the previous two to three months (American Diabetes Association [ADA], 
2017b). In a landmark study, the Diabetes Control and Complications Trial Research Group (DCCT; 1993) 
found that maintaining near normal HbA1c greatly reduces risks associated with diabetes. Adherence to 
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diabetes management tasks and the implementation of an intensive insulin treatment have been found to be 
associated with optimal glycemic control (i.e., HbA1c; DCCT, 1993). Although the recommended level of 
HbA1c for all children and adolescents with T1DM is <7.5% (ADA, 2017a), the DCCT found that near-
normalization of blood glucose levels was significantly more difficult to obtain among adolescents than 
among adults (DCCT, 1993). Normalization of blood glucose levels may be more difficult during 
adolescence due to hormonal changes associated with puberty, which may alter insulin sensitivity, thus 
making glycemic control more difficult (Anderson, Brackett, Ho, & Laffel, 1999; Dabadghao, Vidmar, & 
Cameron, 2001; Moran, 2002). Additional factors, such as increasing levels of physical activity and 
changes in nutritional intake, may also impact glycemic control during adolescence (Wysocki, Buckloh, 
Lochrie, & Antal, 2005). Furthermore, increasing levels of non-adherence may also contribute to 
significant deterioration of glycemic control observed during this developmental period (Du Pasquier-
Fediaevsky et al., 2005).  
 Although metabolic control may be considered a measure of adherence, direct methods involving 
the measurement of biological specimens (such as those involved in HbA1c blood assays) measure 
outcomes rather than the process of adherence to medical recommendations (Kyngäs, Kroll, & Duffy, 
2000). While research has demonstrated that adherence to T1DM management tasks is strongly correlated 
with metabolic control (Hood, Peterson, Rohan, & Drotar, 2010), this relationship is not always found. The 
lack of relationship between adherence and metabolic control may be a function of various biopsychosocial 
factors that influence HbA1c (Anderson et al., 1999; Dabadghao et al., 2001; Moran, 2002; Wysocki et al., 
2005) independent of adherence. Therefore, measurement of both adherence to T1DM management tasks 
and metabolic control are vital to understanding both the process and outcome associated with T1DM self-
care.  
Sleep in Youth with T1DM  
Sleep Quality in Youth with T1DM 
 Despite evidence of the prevalence of poor sleep in healthy youth, as well as those with chronic 
illness, there is a paucity of research assessing sleep among youth with T1DM. The majority of emerging 
research suggests that youth with T1DM experience more frequent and severe sleep disturbances than 
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youth without chronic illness (Blanz et al., 2012; Caruso et al., 2014; Matyka et al., 2000; Monaghan et al., 
2012; Perfect et al., 2012) and greater daytime sleepiness (Adler, Gavan, Tauman, Phillip, & Shalitin, 
2016), although these findings are not universal (Adler et al., 2016; Estrada, Danielson, Drum, & Lipton, 
2012). Nearly 76% of youth with T1DM report insufficient sleep (Estrada et al., 2012). Barone and Menna-
Baretto (2011) suggest underlying bioregulatory processes (i.e., hypoglycemia, poor glycemic control, and 
rapid glycemic change) may account for these sleep difficulties (see Figure 2).   
 Defining sleep quality. Although sleep quality is accepted as a clinical construct, it represents a 
complex and multifaceted phenomenon that is not so readily defined. “Sleep quality” represents a 
constellation of various aspects of sleep, including quantitative (e.g., duration, sleep onset latency, arousals 
from sleep) as well as subjective aspects such as “depth” or “restfulness.” The exact elements of sleep 
quality are increasingly unclear as they may differ between individuals in relative importance (Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1988).  
 Measurement of sleep quality. Given the inherent subjective nature of sleep quality, objective 
measures of sleep, such as actigraphy and PSG can provide estimates of continuity of sleep (Meltzer et al., 
2013) and may correlate with perceived quality of sleep, but they do not provide information regarding 
subjective quality (Buysse et al., 1988; Meltzer et al., 2013). Subjective measures of sleep quality provide 
valuable information regarding the perception of individual’s sleep-related behaviors and patterns that 
objective measures are unable to measure (Lewandowski et al., 2011). As such, subjective report measures 
are considered essential aspects of comprehensive sleep evaluations (Lewandowski et al., 2011).  
 Objective measurement of sleep quality. Research examining sleep quality in youth with T1DM 
has utilized both objective and subjective measures. Studies utilizing PSG have demonstrated that youth 
with T1DM experience alterations in sleep architecture and more frequent nocturnal arousals than healthy 
controls (Matyka et al., 2000; Perfect et al., 2012, Pillar et al., 2003). In a study examining sleep, glucose, 
and daytime functioning, Perfect and colleagues (2012) found that youth with T1DM (ages 10 – 16, n = 50) 
spent significantly more time in stage 2 sleep2 and less time in restorative stage 3 sleep3 than healthy 
controls (n = 40). Although only a small percentage of sleep was affected (i.e., approximately 5% based on 
seven hours of sleep), such alterations in sleep architecture may have serious consequences for the amount 









estimate that youth with T1DM spend 21 minutes less in slow wave sleep (SWS; stage 3) than healthy 
controls, which would result in an average loss 2.45 hours of SWS per week.  This is particularly 
concerning given that this pattern of sleep architecture is associated with daytime sleepiness, decreased 
mood, difficulties with behavior, decreased quality of life, and school performance (Perfect et al., 2012). 
Furthermore, recent research examining the relationship between sleep duration and diabetes management 
found that an increase in sleep of only 15- to 20-minutes translates to a one-event increase in both blood 
glucose checks and average daily insulin bolus in adolescents with T1DM (McDonough et al., 2017).  
 Additionally, the impact of nocturnal hypoglycemia on sleep quality in youth with T1DM has 
been examined. Hypoglycemia frequently occurs in youth with T1DM, particularly during sleep (Davis, 
Russell, Keating, Jones, & Byrne, 1997). This is concerning because nocturnal hypoglycemia events are 
typically asymptomatic (Ahmet, Dagenais, Barrowman, Collins, & Lawson, 2011) and are associated with 
increased risk for seizure or coma (Davis et al., 1997).  
 At this time, it is unclear how nocturnal hypoglycemia may impact sleep quality in youth with 
T1DM. Two studies have demonstrated that nocturnal hypoglycemia does not appear to affect sleep 
continuity in youth with T1DM. However, in a study assessing the interaction between nocturnal 
hypoglycemia and sleep in children with T1DM (mean age = 12.6, n = 15), Pillar and colleagues (2003) 
observed significant alterations to sleep architecture in youth with T1DM who experienced nocturnal 
hypoglycemia. Specifically, nocturnal hypoglycemia appears to deepen sleep through increased sleep 
efficiency, decreased sleep onset latency, and greater overall total amount of sleep. These findings are 
consistent with the hypothesis that nocturnal hypoglycemia would not result in arousal from sleep and are 
particularly alarming in light of the known risks associated with hypoglycemia (i.e., seizure and coma) as 
they suggest youth are less likely to wake in order effectively intervene and prevent further decrease in 
blood glucose levels. Differing results across these three studies may be a function of varying 
methodological approaches assessing hypoglycemia. Pillar and colleagues (2003) defined hypoglycemic 
events more stringently (i.e., <2.7 mmoL/L) than other studies (i.e., <3.5 mmoL/L; Matyka et al., 2000; 
Porter et al., 1996), suggesting that the severity of hypoglycemia may play a key role in whether and to 
what extent sleep architecture is affected by nocturnal hypoglycemia.  
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 Finally, T1DM appears to be associated with increased risk for apneic events during sleep in 
children and early adolescents. Villa and colleagues (2000) found that children and early adolescents (ages 
5 – 11, n = 25) with T1DM experience more frequently apneic events compared to healthy controls (n = 
20). Additionally, children and early adolescents in poor control (HbA1c ≥ 8.0%) experienced more 
frequent apneic events than those in good control (HbA1c ≥ 7.9%).   
 Summary. Taken together, current research examining sleep quality using objective measures of 
sleep suggest that T1DM-related disease processes may interact with underlying bioregulatory mechanisms 
involved in sleep resulting in altered sleep quality in youth with T1DM. Although this line of research is 
crucial for understanding sleep quality in youth with T1DM, its contribution is limited, as it does not 
consider youths’ subjective experiences of sleep quality.  
 Subjective measurement of sleep quality. Understanding the subjective experience of sleep 
quality is critical, yet a limited number of studies have utilized subjective report measures to examine sleep 
quality with youth with T1DM. Initial evidence suggests that youth with T1DM experience decreased sleep 
quality compared to healthy appears (Blanz et al., 1993; Caruso et al., 2014; Varni et al., 2009), although 
this finding is not universal (Adler et al., 2016; Estrada et al., 2012; Yeshayahu & Mahmud, 2010). Current 
research examining sleep quality using subjective report measures is methodologically diverse in terms of 
reporter, assessments used, and aspects of sleep quality assessed.  
 Sleep disturbance. Emerging evidence suggests that youth with T1DM experience significant 
sleep disruptions and disturbances. A recent study found approximately 60% of youth with T1DM 
experienced clinically significant sleep disturbances, based on parent report (Perfect, 2014). Additionally, it 
appears that youth with T1DM experience greater sleep disturbances than their otherwise healthy peers. In 
a study examining parent-reported sleep, neurocognitive, and behavioral functioning in children and 
adolescents, Caruso and colleagues (2014) found that children and adolescents with T1DM (ages 6 – 16, n 
= 46) experienced significantly greater sleep disturbances compared to healthy controls (n = 36). This is 
consistent with the finding that adolescents with T1DM (ages 17 – 19, n = 93) report experiencing greater 
sleep disturbances than healthy controls (n = 93; Blanz et al., 1993). Although Blanz and colleagues (1993) 
assessed sleep disturbances in adolescents (ages 15 – 17), it was done so at the symptom level, and they did 
not provide information regarding aspects of sleep disturbance assessed.   
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 Despite converging evidence that youth with T1DM experience decreased sleep quality associated 
with sleep disturbances, only two studies have assessed adolescents’ perspective of sleep disturbances 
using validated and reliable measures designed specifically to assess sleep disturbances and quality (i.e., 
Jaser et al., 2016; McDonough et al., 2017). In a study examining associations between sleep disturbances, 
diabetes management, and glycemic control, Jaser and colleagues (2016) found approximately 20% of 
adolescents and young adults with T1DM (ages 13-20, n = 159) reported poor to very poor sleep quality. 
Notably, while McDonough and colleagues (2017) utilized a validated and reliable measure of sleep 
quality, researchers did not provide specific descriptive information regarding adolescent-reported sleep 
quality. 
 Finally, Turner and colleagues (2016) assessed sleep quality in high school seniors with T1DM; 
however, sleep quality was assessed in high school seniors with T1DM using only a single item (i.e., “How 
well did you sleep last night?”). Generalizability of results from Turner et al. (2016) to adolescents younger 
than seniors in high school may be limited. 
 Use of parent-report measures to assess youths’ sleep disturbances (e.g., Caruso et al., 2014; 
Perfect, 2014) is methodologically concerning given that previous research has shown that information 
provided by proxy reporters is not necessarily equivalent to youths’ own perspective (Achenbach, 
McConaughy, & Howell, 1987). Parents may underestimate their child’s sleep disturbances throughout the 
night because they are not typically present while the child is sleeping (Schreck & Richdale, 2011). 
Furthermore, parent reports of adolescents’ sleep may represent the time adolescents are in their bedrooms 
at night (Short, Gradisar, Lack, Wright, & Chatburn, 2013) rather than time spent sleeping. Parents may 
overestimate the amount of sleep adolescents obtain, thus reporting on their child’s sleep in a more 
idealized way (i.e., estimating adolescent went to bed earlier and obtained more sleep than adolescents 
reported). If parents do not provide an accurate estimate of adolescents’ sleep, they may not be aware of, 
and therefore underreport, issues associated with restricted sleep (Short et al., 2013) or quality of sleep.  
 In light of these limitations, additional research is necessary to better understand adolescents’ 
perspective of their own sleep disturbances and quality. It is vital that future research assess sleep 
disturbances throughout adolescence using a standardized, reliable, and valid measure of sleep disturbances 
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and quality. Addressing these methodological limitations will improve our understanding of the 
relationship between T1DM and sleep disturbances in adolescents with T1DM.  
 Total Sleep Time. A paucity of research has examined the relationship between T1DM and total 
sleep time in youth with T1DM. Emerging evidence suggests that youth with T1DM receive similar 
amounts of sleep as healthy controls (Estrada et al., 2012; Yeshayahu & Mahmud, 2010); however, it is 
unclear how methodological issues may impact these findings.  
 A major methodological weakness of the current research examining total sleep time in youth with 
T1DM is the use of non-equivalent control groups. Estrada and colleagues (2012) compared child and 
adolescent (ages 5 – 19) reports of typical sleep duration to their relatives, who ranged in age from 5.2 – 
82.5 years. Given that age is the most significant factor associated with sleep, comparing adolescents’ sleep 
to individuals of such a wide age range may be inappropriate. Despite this limitation, results are consistent 
with findings of Yeshayahu and Mahmud (2010) who compared sleep duration in adolescents (ages 12 – 
18) to matched controls of similar age. 
 In both studies, children and adolescents provided estimates of their “typical” sleep times in order 
to estimate typical sleep duration. Although validity and reliability data for reporting estimated school night 
and weekend times against sleep diary and actigraphy has been documented (Woflson et al., 2003), there is 
evidence to suggest that adolescents’ estimates of sleep duration may be skewed. Wolfson and colleagues 
(2003) examined adolescents’ (ages 13.8 – 19.9, n = 302) self-reported survey estimates of sleep patterns in 
comparison to sleep diary and actigraphy. Adolescents reported receiving more sleep on the weekends, 
going to bed earlier on school nights, and waking later on the weekends on the self-report survey measure 
than on the sleep diary and actigraphy (Wolfson et al., 2003). These results suggest that adolescents 
actually overestimated the amount of sleep they obtained on weekends and underestimated the time they 
went to bed. Although total sleep duration did not significantly differ on school nights, the finding that 
adolescents tended to overestimate weekend sleep suggests that self-report survey measures of adolescents’ 
sleep may not be sufficient for estimating adolescents’ sleep duration.  
 Given these methodological limitations, future research should examine adolescent sleep duration 
using other reliable measures of sleep, such as sleep diaries or actigraphy. Sleep diaries are likely more 
accurate than retrospective measures of sleep over a longer period of time given that sleep diaries are 
22 
completed closer to actual timing of sleep. Additionally, it will be important that future research use age-
matched control groups in order to better understand sleep across the lifespan.  
  Fatigue. To date, only one study has examined fatigue in children and adolescents with T1DM. 
Given clinical observation that fatigue is often associated with T1DM, Varni and colleagues (2009) 
examined various aspects of fatigue (i.e., general fatigue, sleep/rest fatigue, cognitive fatigue) in youth with 
T1DM compared to youth receiving active treatment for cancer and healthy controls. Based on both parent- 
and youth self-report, participants with T1DM reported similar levels of fatigue as participants with cancer 
and significantly more fatigue across all domains than healthy controls. Interestingly, parents reported that 
youth with T1DM experienced greater cognitive fatigue than youth with cancer. Results suggest that 
fatigue may be an important construct to assess to better understand how it may impact daily functioning in 
adolescents with T1DM.   
Sleep and Disease Outcomes in Youth with T1DM 
 Adherence. To date, four studies have examined the relationship between sleep and adherence to 
diabetes management tasks in youth with T1DM. Hazen and colleagues (2015) examined the relationships 
among sleep difficulties, adherence, and glycemic control among children and adolescents (ages 10 – 18). 
Sleep difficulties were assessed using four items (i.e., ‘overtired without good reason’, ‘sleeps more than 
most kids during the day and/or night’, ‘sleeps less than most kids’, and ‘trouble sleeping’) from the Child 
Behavior Checklist parent-report measure (Achenbach, 2001). Adherence to diabetes management tasks 
was assessed using child and adolescent reports of adherence during the previous two weeks and average 
daily blood glucose checks. Results suggest that sleeping more than most youth is associated with poorer 
adherence to diabetes management tasks. It may be that sleeping too much may impact diabetes 
management by interfering with the timing of care activities (Hazen et al., 2015). For example, children 
who sleep too much may delay or even miss times when care activities are required, such as blood glucose 
checks, insulin injections, or eating. More recent research suggests sleep duration, and not sleep quality, is 
associated with frequency of blood glucose checks, such as longer sleep duration is associated with more 
frequent blood glucose checks (Jaser et al., 2016; McDonough et al., 2017; Turner et al., 2016).  
 Given the limited scope of research examining the relationship between sleep and adherence, 
specifically with regards to aspects of sleep and adherence, additional research is needed to better 
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understand associations among aspects of sleep and adherence to diabetes management tasks. Furthermore, 
it will be important that measures assess adolescents’ perspective of their sleep quality, given the 
aforementioned limitations with parent reports of sleep in children. 
 Metabolic control. A limited number of studies have examined the relationship between sleep 
and metabolic control. Research suggests that children and adolescents who sleep more than most youth 
have poorer metabolic control (Hazen et al., 2015); however, typical sleep duration in adolescents is not 
associated with HbA1c (Yeshayahu & Mahmud, 2010). Given the cross-sectional nature of the previous 
studies, it is unclear if sleep duration is a symptom or cause of poor glycemic control in youth with T1DM. 
One explanation may be that glycemic control and blood glucose levels affect sleep at a biophysiological 
level, which is consistent with the finding that youth with T1DM who are in poor control experience 
significant altered sleep continuity (i.e., less time in restorative stage 3 sleep and greater time in lighter 
stage 2 sleep; Perfect et al., 2012).  
 Although difficulties with sleep initiation are associated with poorer metabolic control (Happe, 
Treptau, Ziegler, & Harms, 2005), additional research suggests that disturbed sleep is not always associated 
with HbA1c (Blanz et al., 1993; Caruso et al., 2014; Jaser et al., 2016). Recent research suggests better sleep 
quality is associated with lower HbA1c, but only among male adolescents and young adults, and not females 
(Jaser et al., 2016). Taken together, current research suggests that specific aspects of sleep disturbances 
may be associated with metabolic control, rather than sleep disturbances in general. Given the 
aforementioned limitations associated with the studies by Blanz and colleagues (1993) and Caruso and 
colleagues (2014), it is vital that future research examine the relationship between adolescents’ perspective 
of sleep disturbances and metabolic control using a standardized, reliable, and valid measure of sleep 
disturbances. 
 Notably, sleep and metabolic control may be complicated by the occurrence of the “dawn 
phenomenon,” particularly in adolescents with T1DM. The dawn phenomenon is “an increase in either the 
insulin requirements or the plasma glucose concentration, in the absence of hypoglycemia or waning 
insulin levels, occurring between the hours of 0400 and 0800” (Carroll & Schade, 2005, pp. 55-56). 
Clinically, the dawn phenomenon is known to increase morning blood glucose levels resulting in a transient 
increase of 10 mg/dL or an increase in required insulin of at least 20% from overnight nadir (i.e., lowest 
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level). The dawn phenomenon is known to affect approximately 54% of all individual with T1DM. The 
most likely mechanism underlying the dawn phenomenon is the nocturnal release of growth hormone; 
however, the exact pathway through which the dawn phenomenon occurs is unknown. The peak in 
production of growth hormone during puberty may, in part, explain the need for increased insulin during 
adolescents (Carroll & Schade, 2005). Furthermore, given that fasting hyperglycemia is associated with 
both greater daytime blood glucose levels and subsequent poorer glycemic control (Carroll & Schade, 
2005), the dawn phenomenon may have far-reaching implications for disease outcomes in T1DM (e.g., 
poorer metabolic control). Clinically, early morning hyperglycemia can impact the choice, timing, and dose 
of nighttime insulin as well as programming of continuous subcutaneous insulin infusion pumps (Carroll & 
Schade, 2005) in order to counteract the effects of the dawn phenomenon on blood glucose and overall 
metabolic control.  
 Summary. Current research examining the relationship between sleep quality and diabetes 
outcomes is limited. Emerging evidence suggest that sleep quality may be associated with adherence to 
diabetes management tasks and metabolic control; however, given significant methodological limitations, 
future research is necessary to understand adolescents’ perspectives of their own sleep quality as it relates 
to diabetes outcomes. Furthermore, youth with T1DM experience similar levels of fatigue as youth 
undergoing active cancer treatment (Varni et al., 2009). Therefore, consideration should be given to the 
potential impact of fatigue and daytime sleepiness as they relate to metabolic control and adherence to 
diabetes management.  
 Potential mediators of the relationship between sleep and disease outcomes. While multiple 
studies have demonstrated that childhood sleep problems predict the development of symptoms of anxiety, 
depression, and neurocognitive functioning in healthy adolescents over time (Beebe, 2011; Moore et al., 
2009; Moore & Meltzer, 2008; Sarchiapone et al., 2014), a limited number have considered these 
relationships in youth with T1DM. This is particularly necessary given the finding that individuals with 
T1DM are at increased risk for difficulties associated with mood (Kovacs et al., 1997; Northam et al., 
2004) and neurocognitive deficits (Caruso et al., 2014; Desrocher & Rovet, 2004; Gaudieri et al., 2008; 
Northam et al., 2006), both of which are implicated in negatively affecting T1DM adherence and glycemic 
control (Bagner et al., 2007; Bernstein et al., 2013; Johnson et al., 2013; Lawrence et al., 2005; Whittemore 
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et al., 2002). As such, it is extremely important to consider the impact of sleep on internalizing symptoms 
and neurocognitive functioning, as well as the implication for diabetes management among youth with 
T1DM.  
 Current research regarding the relationship between sleep, internalizing symptoms, neurocognitive 
functioning, and diabetes-related outcomes was reviewed within the context of a mediation model 
presented in Figure 3. In the model, aspects of sleep (i.e., sleep quality, daytime sleepiness, and total sleep 
time) are hypothesized to impact T1DM-related outcomes (i.e., adherence and glycemic control) through 
internalizing symptoms and neurocognitive functioning. Additionally, Table 1 summarizes literature 
regarding the associations among sleep, internalizing behaviors, neurocognitive functioning, and diabetes 
outcomes in youth with T1DM. 
 Psychological functioning. There is robust support for the relationship between impaired sleep 
and greater internalizing symptoms (i.e., anxiety, depression, withdrawal, somatization) in healthy 
adolescents (Beebe, 2011; Fallone et al., 2002). Research has demonstrated that sleep difficulties are 
associated with an increase in symptoms of depression and anxiety in healthy adolescents (Morrison, 
McGee, & Stanton, 1992; Roberts, Roberts, & Chen, 2001; Wolfson & Carskadon, 1998). Longitudinal 
research examining the sleep and internalizing behavior suggests sleep problems in early childhood (i.e., 3-
4 years of age) predict higher levels of anxiety and depression during middle childhood and adolescence 
(Gregory, Eley, O’Connor, & Plomin, 2004; Gregory & O’Connor, 2002). While anxiety and depression 
are dimensions of internalizing difficulties, there is value in examining separate clusters of symptoms 
unique to each diagnostic category. 
 Depression. Elevated rates of depressive symptoms have been identified in studies examining 
sleep problems among adolescents (Morrison et al., 1992; Roberts et al., 2001). Research examining the 
relationship between sleep and symptoms of depression is often cross-sectional in nature (e.g., Johnson, 
Roth, Schultz, & Breslau, 2006; Moore et al., 2009; Pasch, Laska, Lytle, & Moe, 2010; Roberts et al., 
2001; Wolfson & Carskadon, 1998), which fails to capture the causal relationship between sleep and 
depression; however, longitudinal research has demonstrated a bidirectional relationship between sleep and 
depression, such that more symptoms of depression are associated with more disrupted sleep, which in turn 











Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 




old, n = 45), 
adolescents 
(12.2-17.9 years 
old, n = 45), 
young adults 
(18-30 years old, 
n = 64), each 
group had 
healthy control 
group with same 
sample size† 
Method: Adolescent Sleep 
Wake Scale (going to bed, 
falling asleep, maintaining sleep, 
reinitiating sleep, wakefulness, 
total score), modified Epworth 
Sleepiness Scale, additional 
sleep parameters (daytime sleep 
duration, nocturnal sleep 
duration, snoring/breathing 
problems during sleep) 
 
Results: No significant 
difference between adolescents 
with T1DM and healthy controls 
on ASWS, adolescents with 
T1DM reported fewer 
difficulties with disorder 
breathing, daytime sleepiness 
was significantly lower among 
adolescents with T1DM than 
healthy controls 











Results: Poorer sleep quality 
was associated with higher 
levels of depression among both 
adolescents with T1DM and 
healthy controls  






        
Blanz et al., 
1993 
Youth w/ T1DM  
(17-19 years old,  
n = 93), matched 
control group  
(n = 93) 
Method: Semi structured 




Results: Youth with T1DM 
reported significantly more 
sleeping disturbances than 
healthy controls (single 
symptom level) 
Method: Semi structured 
interview, included questions on 
internalizing 
(depression/anxiety) symptoms  
 
Results: Relationship between 
mood and sleep not reported  




        
Caruso et al., 
2014 
Youth w/ T1DM  
(6-16 years old,  
n = 49), healthy 
control group  
(n = 36) 
Method: Sleep Disturbance 
Scale for Children (disorders of 
breathing, initiating and 
maintaining sleep, arousal, 
sleep-wake transition, daytime 
somnolence, sleep 
hyperhidrosis), caregiver report 
Method: Behavior Assessment 
System for Children-2 
(internalizing and externalizing 
behaviors), caregiver report  
 
Method: Behavior Rating 
Inventory of Executive Function 
(behavior regulation and meta-











Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued  
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 
  Results: Compared to controls, 
youth with T1DM reported 
significantly greater sleep 
problems 
Results: Compared to controls, 
youth with T1DM reported 
significantly greater atypicality, 
depression, somatization, and 
withdrawal; T1DM status 
predicted mood through sleep 
Results: EF significantly 
reduced in youth with T1DM 
compared to controls; impaired 
sleep associated with increased 
executive dysfunction; T1DM 
status predicted EF through 
sleep  
   
        
Estrada et 
al., 2012 
Youth w/ T1DM 
(5-19 years old, 
some adults 20+ 
years old n = 78), 
family relatives  
(n = 235) 
Method: Reported previous 
day’s sleep and wake times  
 
Results: No associations among 
T1DM status, sleep duration, 
and insufficient sleep  
N/A N/A N/A N/A N/A 
        
Happe et 
al., 2005 
Youth w/ T1DM 
(3-18 years old,  
n = 46) siblings 
(4-23 years old,  
n = 50), parents 
(n = 75) 
Method: Standardized restless 
leg syndrome questionnaire (3 
questions); follow-up clinical 
evaluation with medical provider 
to confirm diagnosis 
 
Results: No significant 
difference in RLS symptoms and 
frequency of diagnosis between 
youth with T1DM and controls  




        
Hazen et 
al., 2015 
Youth w/ T1DM 
(10 – 18 years 
old, n = 72) and 
their parents 
Method: Child Behavior 
Checklist, 4 sleep disruption 
questions: ‘overtired without 
reason’, ‘sleeps more than most 
kids during the day and/or 
night’, sleeps less than most kids 
during the day and/or night’, 




Results: 15% reported trouble 
sleeping, 22% reported 
overtired, 29% reported slept 
more than most, 18% reported 
slept less than most 











Results: Greater depressive 
symptoms associated with 
sleeping more, being overtired, 





























Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 
Jaser et al., 
2016 
Adolescents and 
young adults w/ 
T1DM (13 – 20 
years old, n = 
159) 
Method: Pittsburgh Sleep 
Quality Index (sleep duration, 
sleep disturbances, sleep quality) 
 
Results: Approximately 20% 
reported poor or very poor sleep 
quality, average sleep duration 
was 7.4 hour 



















males, but not 
females 
        
Matyka, et 
al., 2000 
Youth w/ T1DM 
(5-13 years old, 




(PSG and PSG 
with metabolic 
profiling; n = 7) 
2. Age and sex-
matched (PSG 
only; n = 15) 
Method: PSG, 3 non-
consecutive nights 








Results: Compared to controls, 
youth with T1DM experienced 
significantly more wakefulness 
during sleep; nocturnal 
hypoglycemia not associated 
with alterations in sleep 
architecture 















stage 4 sleep 
than REM  
N/A 
        
McDonough 
et al., 2017 
Adolescents with 
T1DM (12-18 
years old,           
n = 45) 
Method: 14-night sleep diary, 
Sleep Disorders Scale for 
Children (disorders of breathing, 
initiating and maintaining sleep, 
arousal, sleep-wake transition, 















and HbA1c not 




Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 
  Results: Averaged 
approximately 8.57 hours of 
sleep/night 
   Results: Mean 







mealtime bolus   
  
        
Perfect et al., 
2012 
Youth w/ T1DM 
(10-16 years old, 
n = 50); matched 
controls (n = 40) 
Method: PSG, 3 non-
consecutive nights; actigraphy, 5 
nights 
Location: Participant home 
 
Method: School Sleep Habits 
Survey (sleep patterns, sleep 
disturbances, depressed mood, 
sleepiness, circadian preference) 
 
Results: Compared to controls, 
youth with T1DM experienced 
significantly more stage 2 and 
less stage 3 sleep 
Method: School Sleep Habits 









Results: Daytime sleepiness 
significantly associated 
depressed mood; actigraphy 
parameters not associated with 
mood 















time spent in 








        
Perfect, 2014 Youth w/ T1DM 
(10-16 years old,  
n = 50) 
Method: Sleep diary, 5 nights 
 
Method: Questionnaires: School 
Sleep Habits Survey, Sleep Self-
Report (sleep environment, sleep 
behaviors, daytime sleepiness), 
Children’s Sleep Habits 
Questionnaire-Parent Report  
 
Results: 30% of children 
experience significant sleep 
disturbances; adolescents 
generally slept more on 
weekends than weekdays   
N/A N/A N/A N/A Higher HbA1c 
associated with 





Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 
Pillar et al., 
2003 
Youth w/ T1DM 
(mean age = 
12.6, +/- 2.9, n = 
15) and matched 
controls (age and 
BMI, n = 15) 
Method: PSG, 1 night 













Results: Trend toward youth 
with T1DM with nocturnal 
hypoglycemia experiencing 
increased TST, decreased sleep 
latency, and increased sleep 
efficiency compared to controls. 
Youth with T1DM (non-
hypoglycemic) experienced 
greater brief arousals, increased 
sleep latency and decreased 
sleep efficiency compared to 
healthy controls 








glucose every 5 
minutes; 
hypoglycemia 


















        
Porter et al., 
1996 
Youth w/ T1DM 
(11-15 years old,  
n = 20) 
Method: PSG, 1 night 








Results: Similar sleep and 
arousal indices observed in 
children with and without NH 

























Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 




T1DM (n = 236) 
Method: Perceived sleep quality 
rated for 14 days as a part of 2-
week sleep diary, calculated 
inconsistent sleep quality, 
calculated daily sleep quality 
deviations 
 
Results: Greater average sleep 
quality was associated with more 
consistent sleep quality  
 
Results from sleep diary not 
reported 















and daily sleep 
quality 
deviations   
Method: 
Calculated 

















risk of high 
blood glucose  
N/A 
        
Varni et al., 
2009 
Youth w/ T1DM 
(5-18 years old, 
n = 83), Parents 
of children (2-18 
years old) with 




years old,  
n = 106) 
Parents  
(n = 181) 
  
Healthy youth 
(10-17 years old,  
n = 157) 
Parents (n = 157) 
Method: PedsQL 
Multidimensional Fatigue Scale 
(general fatigue, sleep/rest 
fatigue, cognitive fatigue) 
 
Results: youth with T1DM 
reported significantly worse 
daytime fatigue than healthy 
controls (self-report) and 
comparable fatigue to controls 
with cancer (parent-report) 
 Method: PedsQL 4.0 Generic 




Results: Greater sleep/rest 
fatigue associated with poorer 
emotional functioning 




Table 1. Overview of Research Examining Sleep, Internalizing Symptoms, Neurocognitive Functioning, and T1DM-related outcomes in Youth with T1DM Continued 
 
Study Sample Sleep Internalizing Symptoms Neurocognitive Functioning Adherence Blood Glucose HbA1c 
Villa et al., 
2000 
Youth w/ T1DM 
(5-11 years old; 
n = 25), matched 
controls (n = 20) 
Method: PSG, 1 night 
Location: sleep lab 
Other: pulmonary function 
using spirometry; apneic events 
using TCM3 
 
Results: youth with T1DM 
experienced significantly more 
apneic events that lasted longer 
than controls 



















total apnea and 
central apnea 
events 




Youth w/ T1DM 
(12-18 years old, 
n = 75), matched 
controls (n = 54) 
Method: Sleep timing on 
weekdays and weekends 
 
Results: Compared to controls, 
youth with T1DM slept longer 
on weekdays, but experienced 
less sleep increase on weekends 




Note. N/A = Not assessed; T1DM = type 1 diabetes mellitus, HbA1c = hemoglobin A1c, RLS = restless leg syndrome, PSG = polysomnography, REM = rapid eye movement sleep, TST = total sleep 
time NH = nocturnal hypoglycemia, †only methods and results for the adolescent sub-group are presented in the table 
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Examining the relationship between sleep and symptoms of depression within the context of 
diabetes is warranted as research suggests that youth with T1DM may be at increased risk for experiencing 
symptoms of depression (Blanz et al., 1993; Grey, Cameron, Lipman, & Thurber, 1995; Kovacs et al., 
1997). For example, one study found that nearly one in seven youth (ages 10-18) with T1DM reported 
experiencing clinically significant symptoms of depression, which is nearly double the 12-month 
prevalence rate observed in youth in general (Avenevoli, Swendsen, He, Burstein, & Merikangas, 2015). 
Additionally, in a systematic review of research examining depression among adolescents and young adults 
with T1DM, Johnson and colleagues (2013) found consistent support for greater depressive symptoms 
being associated with higher HbA1c levels, suggesting that youth with poorly controlled T1DM may be at 
even greater risk for difficulties associated with a depressed mood.  
 Several factors may contribute to the increased prevalence of depression in individuals with 
T1DM including adjustment to change in health status, management of complex medical regimens, fear of 
acute complications like hypo and hyperglycemia, and interference with one’s family functioning and 
lifestyle (Hood et al., 2006; Kovacs et al., 1990). 
 Mechanisms. Given the known relationship between adherence to diabetes management tasks and 
metabolic control, adherence may be one possible mechanism through which depression impacts diabetes 
outcomes in adolescents with T1DM. Emerging evidence suggests that depressive symptoms interfere with 
adherence to diabetes management. For example, greater symptoms of depression have been found to be 
associated with less frequent blood glucose monitoring (Hood et al., 2006; McGrady, Laffel, Drotar, 
Repaske, & Hood, 2009), which is a vital aspect of diabetes management. Furthermore, difficulties with 
depression may impact illness management through increasing levels of cognitive burden, which may 
decrease adolescents’ ability to concentrate while engaging in management activities (Grey, Whittemore, & 
Tamborlane, 2002; Hains, Berlin, Davies, Parton, & Alemzadeh, 2006; Herzer & Hood, 2010). Engaging in 
T1DM care activities requires sustained motivation, remembering to check ones’ blood glucose, and 
accurately counting carbohydrate intake and dosing insulin. Numerous symptoms of depression such as 
difficulty concentrating, remembering details, decision-making, decreased motivation, and withdrawal may 
further exacerbate difficulties associated with non-adherence typically observed during adolescence, 
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resulting in even poorer adherence. Therefore, symptoms of depression may play a pivotal role in 
mediating the relationship between sleep and diabetes outcomes in youth with T1DM.   
 Anxiety. Research suggests that symptoms of anxiety negatively impact sleep; for example, greater 
levels of anxiety are associated with shorter sleep duration and daytime sleepiness among healthy 
adolescents (Moore et al., 2009; Sarchiapone et al., 2014). The directionality of the relationship between 
sleep and anxiety is poorly understood (Moore & Meltzer, 2008) as disrupted sleep is a symptom of anxiety 
and disrupted sleep appears to contribute to the impairment associated with anxiety (American Psychiatric 
Association, 2013). Longitudinal research suggests early childhood sleep problems predict the 
developmental of difficulties with anxiety during mid-childhood (Gregory et al., 2004). Examining the 
relationship between sleep and symptoms of anxiety within the context of diabetes is warranted as research 
has shown that anxiety disorders are common among adolescents with T1DM (Kovacs et al., 1997; 
Northam et al., 2004). For example, one study found that 36% of youth with T1DM experienced significant 
difficulty adjusting to their diagnosis and nearly 20% of youth met diagnostic criteria for an anxiety 
disorder 10 years later, most commonly generalized anxiety disorder (Kovacs et al., 1997). A recent study 
found that the rate of subthreshold anxiety symptoms/disorders in youth with T1DM has remained stable 
over time (approximately 20%; Northam et al., 2004).  
 Anxiety has been associated with poorer adherence and metabolic control (Bernstein et al., 2013). 
It has been suggested that extreme levels of anxiety (high or low) may negatively impact functioning such 
as memory, attention, and well-being (Deffenbacher, 1994; Hanoch & Vitouch, 2004), whereas moderate 
levels of anxiety may act in a protective manner to support functioning (Yerkes & Dodson, 1908). As such, 
there may be an identifiable level of anxiety that is “optimal” for promoting effective diabetes 
management. To this end, Herzer and Hood (2010) examined the relationship between anxiety and 
adherence to diabetes management tasks in youth with T1DM. Based on the Yerkes-Dodson model, a 
moderate level of anxiety should promote adherence better than both lower and higher levels of anxiety; 
however, Herzer and Hood (2010) found that as symptoms of anxiety increased, adherence decreased in a 
linear fashion. These results suggest that diabetes management may be negatively impacted by an increase 
in anxiety and that there may be no “optimal” level of anxiety for promoting adherence behaviors. 
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Alternatively, adolescents who experience high levels of anxiety may also experience co-occurring 
psychopathology, which may further interfere with adherence.  
 Mechanisms. Research has shown that worry about diabetes and negative affect negatively impact 
both illness management and glycemic control in youth with T1DM (Mortensen, 2002; Naar-King et al., 
2006; Wiebe, Alderfer, Palmer, Lindsay, & Jarrett, 1994). Anxiety may decrease adolescents’ ability to 
effectively manage their T1DM through its negative impact on memory, attention, and performance on 
tasks. Adolescents with T1DM who experience anxiety may be more likely to forget to carry out various 
management tasks (Herzer & Hood, 2010) and may count carbohydrates or dose insulin with less accuracy. 
Decreased ability to effectively engage in these and other illness management activities may subsequently 
negatively impact metabolic control. 
 Research examining internalizing symptoms and sleep in youth with T1DM. Elevated levels of 
internalizing symptoms are often associated with inadequate sleep in healthy youth. While research has 
demonstrated that youth with T1DM are at elevated risk for experiencing internalizing symptoms, a limited 
number of studies have considered how sleep may impact internalizing behaviors, specifically anxiety and 
depression, in youth with T1DM (Blanz et al., 1993; Caruso et al., 2014; Perfect et al., 2012; Varni et al., 
2009). Initial research suggests that greater levels of internalizing symptoms are associated with poorer 
sleep outcomes, including more daytime fatigue (Blanz et al., 1993; Varni et al., 2009) and daytime 
sleepiness (Perfect et al., 2012). Using meditational modeling, Caruso and colleagues (2014) found that 
T1DM status (i.e., having a diagnosis of T1DM) predicted greater internalizing symptoms through greater 
difficulties with sleep among adolescents.  
 Additionally, emerging evidence suggests that alterations in sleep are associated with both 
increased internalizing symptoms and poorer diabetes outcomes. Perfect and colleagues (2012) found that 
youth who spent a greater proportion of time in stage 2 sleep experienced greater levels of depressed mood 
as well as higher average daily blood glucose values and poorer glycemic control. Notably, it is unclear 
how depressed mood may be associated with T1DM-related outcomes in this study; Perfect and colleagues 
(2012) did not report on this relationship.  
 Current research examining internalizing symptoms in the context of sleep and disease outcomes 
is limited. Although a number of studies have examined all three constructs, only one study has reported on 
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adolescents’ sleep, internalizing symptoms, and T1DM-related outcomes (e.g., Caruso et al., 2014); 
however, their results should be interpreted with caution given the use of parent rather than adolescent 
report regarding adolescent sleep. Research suggests that poor sleep and greater levels of internalizing 
symptoms negatively impact adherence and metabolic control, and that poor sleep is associated with greater 
internalizing symptoms in healthy youth; yet research has yet to consider how sleep quality may influence 
diabetes-related outcomes through internalizing symptoms.  
 Sleep and neurocognitive functioning. Executive functioning (EF) is a broad cognitive term 
describing various meta-cognitive and behavioral regulation skills including problem solving, self-
monitoring, working memory, initiation of behavior, emotional control, shifting cognitive set, attention, 
and inhibition (Donders, 2002; Gioia, Isquith, Guy, & Kenworthy, 2000). Three principal brain circuits 
appear to be responsible for EF including the dorsolateral prefrontal cortex, lateral orbital cortex, and 
anterior cingulate cortex. EF affords humans the ability to problem solve, adapt to the environment, and 
plan, execute, and evaluate goal-directed behavior. Executive dysfunction may result in various deficits 
including difficulties with the initiation and adaptation of behavior in order to meet environmental demands 
(Kinsella, Storey, & Crawford, 2006).  
 Children and adolescents with T1DM may be particularly vulnerable to neurocognitive deficits, 
which may be a function of disease-related processes (e.g., periodic fluctuations in blood glucose) that 
affect the brain’s development (Desrocher & Rovet, 2004). Compared to their healthy peers, children and 
adolescents with T1DM have been found to experience various mild neurocognitive deficits including 
difficulties in executive functioning and inattention (Desrocher & Rovet 2004; Caruso et al., 2014; 
Gaudieri et al., 2008; Northam et al., 2006).  
“Hot” versus “cold” assessment of executive functioning. Traditionally, EF has been assessed 
using “cold” tasks (i.e., tasks involving cognitive processes with little emotional salience and are thought to 
be less emotionally arousing; Chan, Shum, Toulopoulou, & Chen, 2008; Skogil, Egeland, Andersen, Hovik, 
& Oie, 2013). Examples of “cold” EF tasks include Stroop, Wisconsin Card Sorting Task, Trail Making 
Test, and verbal fluency tasks. Alternatively, cognitive processes in situations with stronger emotional 
salience (e.g., beliefs or desires) are often referred to as “hot” activities (Skogil et al., 2013). This may 
involve experiences of punishment and reward, regulation of interpersonal behavior, and decision-making 
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involving emotional and personal interpretation (Chan et al., 2008). An example of a “hot” EF task is the 
Iowa Gambling Task, in which individuals choose between decks of cards that yield either high immediate 
gain but larger future loss, or decks of cards that yield lower immediate gain but small future loss in order 
to optimize profit (Chan et al., 2008).  
Hot and cold EF processes appear to activate different areas of the brain. Hot EF processes have 
been shown to activate areas of the brain associated with emotion regulation and reward processing (e.g., 
orbito-frontal cortex, ventral striatum, limbic system). Cold EF tasks appear to activate different areas of 
the brain, specifically the dorsolateral prefrontal cortex (Castellanos, Sonuga-Barke, Milham, & Tannock, 
2006).    
 Hot and cold executive functioning and T1DM management. Within the context of T1DM, 
effective disease management may involve both “hot” and “cold” EF abilities.  Effective T1DM 
management may, in part, depend on adolescents’ emotional regulation abilities (i.e., “hot” EF). These 
abilities may be important for management-related activities, such as negotiating responsibility sharing of 
management behaviors with the caregivers. Additionally, effective T1DM management likely depends on 
various “cold” EF abilities. These may include the ability to plan, organize, and initiate goal-directed 
behavior (e.g., counting carbohydrates, checking blood glucose, and accurately dosing insulin for the 
purpose of maintaining near-normal blood glucose levels), as well as to monitor progress towards reaching 
a goal. These management behaviors may tap into aspects of “cold” EF because they reflect more affect-
neutral problem-solving behaviors. Notably, “cold” EF tasks associated with T1DM management often 
become “hot,” as these activities occur within an emotionally-salient context (i.e., they are impacted by 
family dynamics and shared management negotiation).  
 While emerging evidence suggests that EF is associated with T1DM outcomes in children and 
adolescents (Bagner et al., 2007; McNally, Rohan, Pendley, Delamater, & Drotar, 2010; Miller et al., 
2013), existing research has not examined the relative contributions of “hot” and “cold” EF to T1DM 
management. Current research examining EF in children and adolescents with T1DM has utilized the 
parent-report version of the Behavior Rating Inventory of Executive Functioning (BRIEF; Bagner et al., 
2007; McNally et al., 2010; Miller et al., 2013). The BRIEF examines various latent aspects of adolescents’ 
EF (e.g., planning, organization, inhibition, working memory, emotional control, etc.) using a list of 
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statements regarding adolescents’ behaviors. Unlike performance-based neuropsychological tests, which 
typically assess only “cold” aspects of EF, Egeland and Fallmyr (2010) suggest that the BRIEF assesses 
both “hot” and “cold” aspects EF in children and adolescents. Specifically, Egeland and Fallmyr (2010) 
suggest that emotion regulation (i.e., emotional control and shifting) may uniquely represent “hot” aspects 
of EF, where as other aspects, such as behavioral regulation, may represent “cold” aspects of EF on the 
BRIEF. Therefore, the BRIEF may be uniquely positioned to examine both “hot” and “cold” aspects of EF 
simultaneously, while also providing valuable ecological insight into issues adolescents may be 
experiencing (Guy, Isquith, & Gioia, 2004).  
 To better understand the relationship between T1DM management and EF, it is important that 
assessment tools of EF examine both “hot” and “cold” aspects of EF processes. Assessment tools 
examining both aspects of EF, such as the BRIEF, may be more relevant to T1DM management than cold 
tasks alone, as cold tasks may be unable to capture the emotionally-laden aspect of T1DM management.  
 Mechanisms. Executive functioning abilities, such as problem solving, self-monitoring, and 
working memory, may play a key role in effective self-management in T1DM given the complexity 
involved in diabetes management (Bagner et al., 2007). For example, children and adolescents with 
executive dysfunction may have greater difficulty reflecting on and integrating previous experiences in 
order to improve their illness management. Additionally, management of T1DM may depend on specific 
EF abilities, such as creating and holding a goal in mind, creating a plan to achieve that goal, organizing 
and adjusting behavior in order to obtain that goal, and attending to relevant information while inhibiting 
non-relevant behaviors that may detract from pursuing that goal. Illness-related care activities likely depend 
upon these skills, such as remembering to check blood glucose regularly, adjusting insulin dosage based on 
blood glucose monitoring, tracking carbohydrate intake, accounting for physical activity, monitoring and 
addressing natural and unexpected fluctuations in blood glucose levels, and carrying and using quick acting 
sugar to treat low blood glucose levels. Research suggests EF skills may be particularly important for 
disease management and metabolic control in adolescents with T1DM. Executive dysfunction may impede 
the effective integration and coordination of various complex management activities, which may negatively 
affect adherence and metabolic control in adolescents with T1DM.  
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 Research examining neurocognitive functioning and sleep in youth with T1DM. Emerging 
evidence has demonstrated that executive functioning may impact diabetes outcomes such as glycemic 
control through its effect on adherence to diabetes management tasks (Bagner et al., 2007; McNally et al., 
2010). While executive dysfunction is associated with decreased adherence to diabetes management tasks 
(McNally et al., 2010) regardless of age (Bagner et al., 2007), EF abilities do not appear to be directly 
associated with glycemic control (McNally et al., 2010; Miller et al., 2013). Rather, McNally and 
colleagues (2010) demonstrated that adherence to diabetes management tasks mediates the relationship 
between EF and HbA1c in children (ages 9 – 11) with T1DM, such that greater executive dysfunction 
predicted poorer adherence, which in turn predicted poorer glycemic control. Although this area of research 
is relatively new, initial findings lend support for the impact of EF on diabetes in outcomes in youth with 
T1DM and underscore the importance of EF to effective management of T1DM. Notably, published 
research examining EF in youth with T1DM has exclusively examined EF using the BRIEF, which is a 
parent-report measure assessing various domains of youths’ EF based on observable behaviors. Research 
has yet to examine adolescents’ perspectives of their own EF and how EF relates to T1DM outcomes.  
 Research has also shown that sleep may have undue influence on executive functioning, which may 
be particularly concerning for adolescents given the pervasiveness of insufficient sleep during this 
developmental period. In a review of correlational, case-control, quasi-experimental, and experimental 
studies examining cognitive, behavioral, and functional consequences of inadequate sleep in children and 
adolescent, Beebe (2011) concluded that difficulties with sleep are generally associated with both 
decreased executive functioning and increased inattention in typically developing children and adolescents. 
Longitudinal research suggests early- to mid-childhood sleep problems predict certain aspects of executive 
functioning during adolescence (Gregory, Caspi, Moffitt, & Poulton, 2009).  
 Although the relationship between sleep and EF is well documented, only one study has examined 
the relationship between sleep and EF within the context of pediatric T1DM (see Table 1; Caruso et al., 
2014). Using mediational analyses, Caruso and colleagues (2014) demonstrated that youth with T1DM 
experienced greater deficits in meta-cognitive skills (i.e., initiation, working memory, planning/organizing, 
organization, and monitoring), which could be accounted for by poorer sleep in youth with T1DM. 
Conversely, sleep difficulties did not mediate the relationship between T1DM and behavior regulation (i.e., 
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inhibition, shifting, emotional control) difficulties in youth with T1DM. Taken together, these findings 
suggest that poor sleep in youth with T1DM may uniquely account for meta-cognitive deficits but not 
behavioral regulation difficulties observed in this population. Although this study is the first study to 
consider the relationship between sleep and EF in the context of adolescents with T1DM, research has yet 
to consider how sleep may influence T1DM-related outcomes through EF in adolescents with T1DM.  
Present Study 
 While sleep is extremely important for the development of children and adolescents, the majority 
of adolescents fail to sleep the recommended amount for their age. A coalescence of various 
biopsychosocial factors conspire to limit both the quality and quantity of sleep for many adolescents. 
Underlying disease processes, as well as other psychosocial and illness-related sequelae, are thought to 
further compound sleep difficulties among youth with chronic illness. Emerging evidence suggests that 
youth with T1DM experience more frequent and greater difficulties with sleep than healthy youth, which 
may be a function of the interaction between underlying disease processes associated with T1DM and 
bioregulatory mechanisms involved in sleep. Insufficient sleep appears to have various negative 
consequences for functioning in healthy adolescents, including increased internalizing behaviors like 
symptoms of depression and anxiety, as well as diminished neurocognitive functioning. Extent literature 
suggests early sleep problems predict increased difficulties with internalizing symptoms and executive 
functioning over the course of development among healthy youth (Gregory et al., 2009; Gregory et al., 
2004; Gregory & O’Connor, 2002). Internalizing symptoms and neurocognitive functioning have been 
implicated in T1DM management and metabolic control (Bernstein et al., 2013; Hood et al., 2006; 
McGrady et al., 2009). Although research suggests that youth with T1DM are at increased risk for the 
development of internalizing symptoms and neurocognitive dysfunction, research has yet to consider how 
these processes may help to explain the potential relationships among sleep, illness management, and 
diabetes outcomes in youth with T1DM.   
 The current study focused on integrating our understanding of the complex relationships among 
sleep, internalizing symptoms, neurocognitive functioning, and T1DM-related outcomes. Upon careful 
review of the existing literature, there appears to be very limited research examining the relationships 
among adolescent-reported sleep quality (i.e., sleep quality, daytime sleepiness, and sleep quantity) and 
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T1DM-related outcomes (i.e., adherence and metabolic control). Furthermore, research has yet to examine 
internalizing symptoms (i.e., depression and anxiety) and neurocognitive functioning (i.e., executive 
functioning) as potential mediators of the relationship between sleep and T1DM-related outcomes. One 
might suppose internalizing symptoms and executive functioning influence the strength of the relationship 
between sleep and T1DM-related outcomes; however, based on a review of extent literature, examining 
internalizing symptoms and executive functioning as mediators (i.e., one that explains the relationship 
between variables of interest) appears to be most appropriate at this time. Therefore, sleep quality/quantity, 
internalizing symptoms, and neurocognitive functioning variables were examined within the context of the 
proposed mediation model (see Figure 3). Examination of the model enables improved understanding of the 
potential pathways through which aspects of sleep may be associated with treatment adherence and 
metabolic control in adolescents with T1DM. It is possible that adolescents’ psychological and 
neurocognitive functioning may help to explain how aspects of sleep quality may impact T1DM-related 
outcomes. In the proposed model, aspects of sleep quality and sleep quantity are hypothesized to influence 
adherence and metabolic control through internalizing symptoms and neurocognitive functioning.  
 As the relationship between sleep and T1DM may be reciprocal in nature, sleep appears to be an 
important, clinically-relevant construct as it is a modifiable behavior that may be targeted for intervention. 
Additionally, given the relationship between sleep, internalizing behaviors, and neurocognitive functioning 
and the known impact of increased internalizing and neurocognitive deficits on illness management and 
outcomes, targeting sleep as a point of intervention in youth with T1DM may improve mood and 
neurocognitive functioning, as well as illness management and diabetes outcomes. 
 The present study aims to address numerous gaps in the research examining sleep in adolescents 
with T1DM: 
1. To examine adolescents’ perceptions of their sleep quality (i.e., sleep disturbances, 
fatigue/daytime tiredness, total sleep time). 
2. To examine whether adolescents’ sleep quality is related to T1DM-related outcomes (i.e., 
treatment adherence and metabolic control).  
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3.  To examine the role of internalizing symptoms (i.e., symptoms of anxiety and depression) and 
neurocognitive functioning (i.e., executive functioning) in mediating the relationship between 
adolescent sleep quality and T1DM-related outcomes.  
Hypotheses 
1. Poorer sleep quality (i.e., adolescent-reported ASWS, CASQ) will be associated with poorer treatment 
adherence (i.e., caregiver- and adolescent-reported SCI-R scores). 
2. Poorer sleep quality (i.e., adolescent-reported ASWS, CASQ) will be associated with poorer metabolic 
control (i.e., HbA1c values). 
3. Less total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep diary) will 
be associated with poorer treatment adherence (i.e., caregiver- and adolescent-reported SCI-R scores). 
4. Less total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep diary) will 
be associated with poorer metabolic control (i.e., HbA1c values). 
5. Adolescents’ sleep quality (i.e., adolescent-reported ASWS, CASQ) will influence treatment 
adherence (caregiver- and adolescent-reported SCI-R) because of the influence sleep has on adolescents’ 
executive functioning (caregiver- and adolescent-reported BRIEF scores), which in turn influences 
treatment adherence.   
6. Adolescents’ sleep quality (i.e., adolescent-reported ASWS, CASQ) will influence treatment 
adherence (caregiver- and adolescent-reported SCI-R) because of the influence sleep has on the level of 
adolescents’ internalizing symptoms (i.e., adolescent-reported BASC-2 Anxiety and Depression subscale 
scores), which in turn influences treatment adherence.   
7. Adolescents’ sleep quality (i.e., adolescent-reported ASWS, CASQ) will influence metabolic control 
(i.e., HbA1c) because of the influence sleep has on adolescents’ executive functioning (caregiver- and 
adolescent-reported BRIEF scores), which in turn influences metabolic control.   
8. Adolescents’ sleep quality (i.e., adolescent-reported ASWS, CASQ) will influence metabolic control 
(i.e., HbA1c) because of the influence sleep has on the level of adolescents’ internalizing symptoms (i.e., 
adolescent-reported BASC-2 Anxiety and Depression subscale scores), which in turn influences metabolic 
control.   
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9. Adolescents’ total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep 
diary) will influence treatment adherence (caregiver- and adolescent-reported SCI-R) because of the 
influence total sleep time has on adolescents’ executive functioning (caregiver- and adolescent-reported 
BRIEF scores), which in turn influences treatment adherence.   
10. Adolescents’ total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep 
diary) will influence treatment adherence (caregiver- and adolescent-reported SCI-R) because of the 
influence total sleep time has on the level of adolescents’ internalizing symptoms (i.e., adolescent-
reported BASC-2 Anxiety and Depression subscale scores), which in turn influences treatment 
adherence.   
11. Adolescents’ total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep 
diary) will influence metabolic control (i.e., HbA1c) because of the influence total sleep time has on 
adolescents’ executive functioning (caregiver- and adolescent-reported BRIEF scores), which in turn 
influences metabolic control.   
12. Adolescents’ total sleep time (i.e., adolescent-reported overall, weekday, and weekend TST on sleep 
diary) will influence metabolic control (i.e., HbA1c) because of the influence total sleep time has on the 
level of adolescents’ internalizing symptoms (i.e., adolescent-reported BASC-2 Anxiety and Depression 















 Eligible participants in the current study included male and female adolescents, ages 12-17 years 
old, and a primary caregiver/guardian. Inclusionary criteria for adolescents included1) fluency in English, 
2) diagnosis of type 1 diabetes mellitus (T1DM) for at least one year prior to study participation, 3) having 
caregiver/guardian who is available to participate, and 4) having no reported history of intellectual 
disability or developmental disorder that would preclude them from reading or understanding study 
questionnaires. Adolescents could not be diagnosed with other chronic illnesses requiring additional 
treatment regimen that may alter their diabetes management. Eligibility criteria for caregivers/guardians 
included 1) residing in the same household as the adolescent, and 2) being fluent in English. Participants 
were recruited from Children’s Hospital of Wisconsin (CHW) Department of Endocrinology (i.e. Diabetes 
Clinic).  
Procedure 
 Eligible participants were recruited from the Diabetes Clinic at CHW. For recruitment purposes, 
demographic information (i.e. patient name, age, sex, medical diagnosis, address, phone number, and 
parent/guardian name) was obtained from clinic databases/medical records prior to obtaining informed 
consent. This information was gathered via a waiver of initial consent to screen records for potential 
participants at CHW. Authorized personnel, including staff members of the Diabetes Clinic and study 
personnel, identified potential participants who met eligibility criteria. Participants were informed of the 
study before or during a regularly scheduled appointment, during a Diabetes Clinic education class, or 
through mailings. Caregivers and adolescents were provided with a brief overview of the study and given 
the opportunity to complete consent procedure in the clinic or over the phone.  
Participation was possible either in clinic or at home using paper-pencil questionnaires or online 
via Qualtrics. Caregivers and adolescents who completed questionnaires online received separate emails 
with instructions on how to complete questionnaires through Qualtrics. Online questionnaires were 
password protected. Passwords were provided in the email provided to participants completing 
questionnaires online. Participants were provided up to six auto emails to remind participants to complete 
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questionnaires through the Qualtrics system. Families were provided postage paid return envelopes to 
return paper-pencil questionnaires to Marquette University. Research assistants provided reminder calls for 
participants who chose to complete paper-pencil questionnaires. Of the complete dyads, where both 
caregivers and adolescents completed questionnaires, most caregivers and adolescents (64%) completed 
questionnaires online. 
Adolescents were sent a $15 gift card to Target and a 5-night sleep diary with instructions after 
completing their questionnaires. Adolescents received an additional $5 gift card to Target after returning 
the 5-night sleep diary. Caregivers were mailed a $10 gift card to Target after completion of caregiver 
questionnaires.   
Measures 
Table 2 lists measures that were used in the present study, including assessed constructs and 
reporter information. Additional scale and subscale scores gathered as a part of the full protocol are not 
discussed here.  
 Demographic characteristics (caregiver and adolescent report). Caregivers and adolescents 
completed demographic questionnaires that included general demographic and illness-related information. 
Caregivers reported on their age, race/ethnicity, household composition, marital status, highest level of 
education obtained, occupational status, and family income. Adolescents reported on their age, 
race/ethnicity, grade, gender, and illness-related information (e.g., use of insulin pump and continuous 
blood glucose monitor).  
 Sleep. 
 Adolescent Sleep Wake Scale (ASWS; adolescent report). The ASWS is a 28-item self-report 
measure designed to assess overall sleep quality in adolescents ages 12-18 (LeBourgeois et al., 2005). The 
ASWS includes five behavioral dimensions associated with quality of sleep, including going to bed, 
initiating sleep, maintaining sleep, reinitiating sleep, and returning to wakefulness. The overall sleep quality 
score is derived from these five dimensions. Adolescents indicated how often they experienced certain 
sleep behaviors during the past month on a six-point Likert scale 1 (Always) to 6 (Never). Higher scores on 
the ASWS represent better sleep quality. The ASWS has demonstrated good internal consistency reliability  
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Table 2. Constructs and Measures Included in the Present Study 
   
Construct Measure Reporter 
Demographics Demographic Characteristics Caregiver, Adolescent 
Sleep Adolescent Sleep-Wake Scale Adolescent 
 Cleveland Adolescent Sleep 
Questionnaire 
Adolescent 
 Modified Consensus Sleep Diary – Core Adolescent 
Internalizing Symptoms BASC-2 SRP-A (Anxiety and 
Depression subscale scores) 
Adolescent 
Executive Functioning BRIEF Caregiver 
 BRIEF-SR Adolescent 
Treatment Adherence Self-Care Inventory-Revised Caregiver, Adolescent 
Metabolic Control Most recent HbA1c Medical Record Review 
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(Chronbach’s alpha = 0.60 - 0.81; Essner, Noel, Myrvik, & Palermo, 2014). Internal consistency for each 
subscale in the present study was examined. Internal consistency ranged from .72 (initiating sleep subscale) 
to .79 (going to bed subscale). On the initiating sleep subscale, two poorly performing items were identified 
(i.e., When it’s time to go to sleep… I feel sleepy and …I lie down, but then get up and come out of the 
bedroom) and removed from the subscale, resulting in improved internal consistency (α = .79). On the 
returning to wakefulness subscale, one item was identified as poorly performing (i.e., In general, I need 
help waking up in the morning). Internal consistency improved from .77 to .85 (Chronbach’s alpha). A total 
of three items were removed from the questionnaire, resulting in good internal consistency (α = .89).  
 Cleveland Adolescent Sleep Questionnaire (CASQ; adolescent report). The CASQ is a 16-item 
adolescent self-report measure examining excessive daytime sleepiness in adolescents ages 11-17 
(Spilsbury, Drotar, Rosen, & Redline, 2007). The overall sleepiness score is derived from four dimensions 
(i.e., sleep in sleep, awake in school, sleep in evening, and sleep during transport). Adolescents indicated 
how frequently they felt sleepy/fall asleep in various situations during the previous week using a five-point 
Likert-type scale: never (0 times per month) to almost every day (5 or more times per week). Higher scores 
on the CASQ reflect greater sleepiness. The CASQ has demonstrated good internal consistency reliability 
(α = 0.89) and is strongly correlated with other measures of sleepiness such as the School Sleep Habits 
Survey and Pediatric Daytime Sleepiness Scale among healthy adolescents and adolescents with sleep 
disordered breathing (Spilsbury et al., 2007). The current study found good internal consistency reliability 
for adolescent-reported daytime sleepiness (α = .88).  
 Modified Consensus Sleep Diary-Core (M-CSD-C; adolescent report). Adolescents completed a 
modified version of the CSD-C (Carney et al., 2012), a standardized, patient-informed sleep diary, for five 
days. Adolescents reported on various aspects of their sleep including time in bed, time fell asleep, 
nighttime awakenings, time of morning awakening, and time arising out of bed. Additionally, adolescents 
were asked to rate the quality of their sleep on a five-point Likert scale, ranging from 1 (very poor) to 5 
(very good). Average total sleep time (TST; total time asleep) was calculated for weekday (Sunday – 
Thursday) and weekend (Friday – Saturday) sleep. Total sleep time was calculated by subtracting estimated 
amount of time to fall asleep and length of awakenings from maximum amount of possible sleep per night 
(i.e., time of final awakening in the morning minus time adolescent attempted to fall asleep). Although 
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adolescents tend to overestimate total sleep time and underestimate wake after sleep onset using sleep 
diaries compared to actigraphy (Honaker, 2015), sleep diaries are considered the “gold standard” for 
subjective sleep assessment (Carney et al., 2012). Adolescents completed analogue (i.e., paper-and-pencil) 
sleep diaries each morning upon awakening.   
 Psychological functioning. 
 Behavior Assessment System for Children, Second Edition, Self-Report of Personality, 
Adolescent (BASC-2 SRP-A; adolescent report). Adolescents completed the BASC-2 SRP-A (176 items), 
which is a “multimethod, multidimensional system used to evaluate the behavior and self-perception of 
children and young adults aged 12 through 21 years” (Reynolds & Kamphaus, 2004, p. 1). The BASC-2 
assesses numerous aspects of behavior, including both adaptive and maladaptive behavior, and personality. 
Adolescents responded to a list of items that describe different situations, behaviors, and personality 
characteristics using a two-point format (adolescents indicate whether the statements are true or false about 
them), or a four-point Likert scale (adolescents indicate the degree to which the statements apply to them, 0 
(Never) to 3 (Always); Reynolds & Kamphaus, 2004). For the purpose of this study, only adolescent reports 
were examined given that prior research suggests adolescents may be the most reliable reporters of their 
own internalizing symptoms (Angold et al., 1987). 
 For the purpose of this study, subscales of interest include Anxiety and Depression. Raw scores 
were converted to T-scores using gender and age-specific norms with higher scores representing poorer 
functioning. Previous literature has shown that internal consistency reliabilities for these two subscales 
among male and female adolescents 12 – 18 years of age were between 0.86 – 0.88. These subscales are 
highly correlated with other adolescent self-reports of anxiety and depression, such as the Achenbach 
System of Empirically Based Assessment Youth Self-Report, the Children’s Depression Inventory, and the 
Revised Children’s Manifest Anxiety Scale (Reynolds & Kamphaus, 2004). The current study found good 
internal consistency reliability for both adolescent-reported anxiety and depression (α = .86).  
 Neurocognitive functioning. 
 Behavior Rating Inventory of Executive Functioning (BRIEF; caregiver report). The BRIEF 
(Gioia et al., 2000) is an 86-item parent-report measure assessing various domains of adolescents’ 
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executive functioning. The measure consists of eight clinical scales assessing abilities related to flexibility 
in problem solving (Shift scale), setting goals and anticipation of future events (Plan/Organize scale), 
inhibition and impulse control (Inhibit scale), regulation of emotional responses (Emotional Control scale), 
initiation of behavior (Initiate scale), and assessing performance during or following a task (Monitor scale). 
Three indices are generated based on these scales: 1) Behavior Regulation Index (BRI; Inhibit, Shift, and 
Emotional Control), 2) Metacognition Index (MI; Initiate, Working Memory, Plan/Organize, Organization 
of Material, and Monitor scales), and 3) Global Executive Composite (GEC), which is derived from the 
BRI and MI scales and represents overall executive functioning (Gioia et al., 2000). Higher scores on the 
BRIEF represent poorer executive function.  
 The measure includes a list of statements that describes adolescents’ behaviors. Parents indicated 
how frequently these behaviors are a problem for their adolescent on a three-point Likert scale (Never, 
Sometimes, Often). Research has demonstrated that the BRIEF is a reliable instrument with internal 
consistencies ranging from .80-.98 for parent and teacher reports (Gioia et al., 2000; McNally et al., 2010). 
The BRIEF has been found to be strongly correlated with other measures of behavioral and attention 
functioning, such as the Child Behavior Checklist, Behavior Assessment for Children, and Connors Rating 
Scale (Gioia et al., 2000). The current study found excellent internal consistency reliability for the Global 
Executive Composite (α = .98).  
 Behavior Rating Inventory of Executive Functioning-Self Report (BRIEF-SR; adolescent 
report). The BRIEF-SR (Guy et al., 2004) is an 80-item adolescent-report measure assessing various 
domains of executive functioning in youth ages 11-18. The scales and indices for the BRIEF-SR are similar 
to those of the BRIEF. The BRIEF-SR includes a list of statements describing various behaviors with 
which adolescents may have difficulties. Adolescents indicated how frequently experience various 
difficulties on a three-point Likert scale (Never, Sometimes, Often). Higher scores on this measure indicate 
poorer executive functioning. The BRIEF-SR is considered a reliable instrument with internal consistencies 
ranging from .72-.96 (Guy et al., 2004), and BRIEF-SR scores are moderately to strongly associated with 
parent reports on the BRIEF (Walker & D’Amato, 2006). The current study found excellent internal 
consistency reliability for the Global Executive Composite (α = .96).  
 Adherence.  
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 Self-Care Inventory-Revised (C SCI-R and A SCI-R; caregiver and adolescent report). 
Adolescents and their caregivers completed the Self-Care Inventory – Revised (Weinger et al., 2005), 
which is a 14-item questionnaire that measures adolescent adherence to a diabetes regimen over the 
previous two weeks. The SCI-R measures various aspects T1DM management, including blood glucose 
monitoring, insulin injections, and maintenance of prescribed diet and exercise recommendations of their 
physician. Participants responded to each item on a five-point Likert scale 1 (never) to 5 (always) with 
higher scores indicating better adherence. The SCI-R was scored by calculating the mean of all items for 
each participant, and, for ease of interpretation, the mean score was converted to a 0 to 100-point scale, 
with higher scores indicating a greater level of adherence (Weinger et al., 2005). Internal consistency 
ratings (Cronbach’s alpha) for a sample of adults ≥18 years of age with T1DM was high (α = 0.87). SCI-R 
is sensitive to differences in adherence between individuals with good versus poor metabolic control 
(Weinger et al., 2005). When comparing different methods of assessing adherence and glycemic control 
among youth with T1DM, Kichler and colleagues (2012) found that the adjusted global score on the SCI 
was a stronger predictor of HbA1c than the 24-hour recall and blood glucose meter data. The current study 
demonstrated adequate internal consistency reliability for both caregiver- (α = .78) and adolescent-reported 
adherence (α = .79).  
Medical Record Data 
 Metabolic control (HbA1c). Hemoglobin A1C (HbA1c) measures blood glucose control during the 
previous two to three months. A medical record review was conducted to obtain HbA1c values from the 
clinic visits one year prior to the day adolescents and caregivers consented to participate in the present 
study. Most recent HbA1c values were used for this study. Higher values represent poorer metabolic control. 







Data Analytic Plan 
 All data were screened for normality of distribution. Data were screened for patterns associated 
with missing data points. Data were missing at random. All composite scores across questionnaires were 
missing less than 25% of the data points required to calculate a given score. Therefore, missing values for 
each questionnaire were replaced by calculating each participant’s average score for a given subscale or 
composite and imputing that value.  
 The distributions of scores were assessed for skewness and kurtosis, with transformations 
conducted as needed (Tabachnick & Fidell, 2007). Due to significant skew, HbA1c values were transformed 
using log transformation. Adolescent-reported depression was highly skewed, but was not corrected for 
mediation analyses as the bias-corrected bootstrap approach to mediation does not make assumptions about 
the shape of the distribution of the indirect effect (i.e., the product of ab paths, see Figure 4; Hayes, 2013). 
Non-parametric analyses were conducted to identify potential covariates associated with adolescent-
reported depression.  
 The impact of outliers was also assessed. Due to the differential impact of outliers on the 
distribution of adolescent-reported daytime sleepiness (i.e., CASQ), adolescent-reported behavioral 
regulation (i.e., BRIEF-SR BRI composite score), adolescent-reported depression (i.e., BASC2-SRP, 
Depression subscale score), adolescent-reported overall executive functioning (i.e., BRIEF-SR GEC 
composite score), and weekend total sleep time, five outliers, one for each measure, were truncated to 3 
standard deviations from the mean of each respective samples composite score.  
 Multicollinearity among normally distributed independent variables (i.e., ASWS, CASQ, 
adolescent-reported Anxiety, and caregiver- and adolescent-reported BRIEF scores) was assessed using 
Pearson correlations and multicollnearity diagnostics (i.e., Tolerance and VIF). Composite scores (i.e., 
BRI, MI, and GEC) on caregiver- and adolescent-reported BRIEF were highly collinear (i.e., r ≥ .90, 
Tolerance ≤ 0.1, and VIF ≥ 10). Therefore, only caregiver- and adolescent-reported Global Executive 





Figure 4. Conceptual model for simple mediation. X = Independent Variable, M = Mediator, Y = 
Dependent Variable, a path = effect of X on M, b path = effect of M on Y, while holding X constant, ab = 
indirect effect of X on Y through M, c’ = estimates the direct effect of X on Y holding M constant, c = total 
effect of X on Y, in other words c’ + ab. 
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Guidelines for required sample size for common statistical approaches to simple mediation models 
suggests a sample size of 80 participants provides sufficient power to detect a medium effect for a (X ! M) 
and b (M ! Y, controlling for X) pathways for a fully mediated model utilizing a bias-corrected bootstrap 
approach (Fritz & MacKinnon, 2007; see Figure 4). Biased-corrected bootstrap approach to mediation is 
considered the most robust approach for testing indirect effects for mediation analyses, though risk for 
Type I error increases with small sample sizes (Fritz & MacKinnon, 2007; MacKinnon et al., 2004). 
Despite these concerns, research demonstrates the bias-corrected bootstrap approach is the single best 
method for testing indirect effects (MacKinnon, Lockwood, & Williams, 2004) and is considered 
advantageous to normal theory approach as there are no assumptions regarding the shape of the sampling 
distribution for ab (Hayes, 2013).  
 All mediation analyses were conducted using bias-corrected bootstrap approach to simple and 
parallel multiple mediation (see Figure 5; Hayes, 2013). The constituent parts of a simple mediation model 
include estimates of the direct effect (c’) of a predictor variable (X) on an outcome variable (Y), holding the 
mediator (M) constant. The indirect effect of a predictor variable on an outcome variable through a 
mediator is the product of the a and b paths (Hayes, 2013). The PROCESS macro (version 2.16.3, 2016) for 
SPSS was utilized to calculate both direct and indirect effects for the mediation models. Mediation models 
were performed using ordinary least squares (OLS) path analysis. The PROCESS macro generates 
confidence intervals for each effect, where the significance of the effect is determined by the presence of 
zero within the confidence interval. Significance is observed when the confidence interval does not contain 
zero (p < .05; Vazsonyi et al., 2015).    
 There are numerous approaches for examining the indirect effect. Research has demonstrated one 
of the most robust approaches to estimating indirect effects is the bias-corrected bootstrap approach (Fritz 
& MacKinnon, 2007). The bootstrapping procedure is a part of a class of procedures that utilize resampling 
methods. With this approach, the original study sample size (n) is thought to represent the larger population 
from which it was drawn. Observations from the original sample are resampled with replacement a set 
number of times (ideally thousands of times) generating an empirically derived representation of the 
sampling distribution for the indirect effect. This representation is also utilized to develop confidence 






Figure 5. Conceptual model for parallel multiple mediation. X = Independent Variable, M = Mediator, Y = 
Dependent Variable, a path = effect of X on M, b path = effect of M on Y, while holding X constant, ab = 
indirect effect of X on Y through M, c’ = estimates the direct effect of X on Y holding M constant, c = total 
effect of X on Y, in other words c’ + ab. 
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confidence intervals are considered more accurate than the normal theory-based Sobel test because it does 
not make assumptions about the distribution of the sample (Fritz & MacKinnon, 2007; Hayes, 2013). The 
bias-corrected bootstrap approach was selected over the causal steps approach popularized by Baron and 
Kenny (1986) as it has been criticized for its ability to effectively detect mediation effects (Fritz & 
MacKinnon, 2007; Hayes, 2013; Vazsonyi et al., 2015). For the present study, all models were performed 
with 5,000 bootstraps, unless otherwise stated.  
The impact of multivariate outliers on the bootstrapping approach to mediation analysis is largely 
unknown. In principle, multivariate outliers may have a substantial impact on model estimates, especially if 
the original sample size is very small. That is because an unusual case or two are likely to be resampled 
multiple times, which can distort results of analyses. However, research has yet to examine just how much 
outliers can impact bootstrap analyses (Hayes, 2013). For the present study, models were initially run to 
include multivariate outliers and compared to models with multivariate outliers removed. Multivariate 
outliers were identified using linear regression for predictor and mediator variables. Mahalanobis distance 
was determined for each combination of predictor and mediator variables and compared against the chi-
square distribution. A significant cut-off point of p < .001 for the chi-square distribution was utilized to 
identify multivariate outliers (Tabachnick & Fidell, 2007). Exclusion of multivariate outliers did not 
significantly alter results of mediation models, therefore, only results of models including all available data, 
including multivariate outliers, are presented.  
 The present study proposed estimation of numerous simple mediation models; however, parallel 
multiple mediation is recommended when examining multiple mechanisms through which a given 
antecedent (X) may influence a consequent (Y). Parallel multiple mediation looks similar to simple 
mediation, except that it includes more than one mediator. While mediators are examined simultaneously, 
they are considered independent from one another (i.e., mediators do not causally influence one another; 
Hayes, 2013). When possible, parallel multiple mediator models are advantageous to simple mediation 
models as they are thought to increase power for tests of indirect effects and allow for comparison of 
indirect effect sizes of various mediators. Indirect effects of parallel multiple mediation models are 
interpreted in a similar fashion to simple mediation models. Similar to simple mediation models, only one 
indirect effect is interpreted at a time, but while holding all other mediators constant (Hayes, 2013). Simple 
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mediation models were performed for hypotheses examining single independent, dependent, and mediator 
variables.  
Descriptive Analyses  
 One-hundred and thirty-three caregiver-adolescent dyads were recruited for the purpose of this 
study. Analyses were based on a sample of 81 caregiver-adolescent dyads. There were a total of five 
unpaired caregivers and adolescents. Adolescents who did not complete questionnaires or who were a part 
of an incomplete dyad (i.e., non-completers) were compared to adolescents who were part of an intact dyad 
(i.e., completers) on age and T1DM-related characteristics. Non-completers (M = 9.93, SD = 2.29, range = 
6.50 – 15.00) had significantly poorer metabolic control than completers (M = 8.50, SD = 1.76, range 5.00 
– 14.00), t(73.49) = 3.63, p < .001. Completers and non-completers did not significantly differ on age or 
other T1DM-related characteristics, such as length of diagnosis and age at diagnosis.   
Descriptive statistics for primary caregiver demographic and household characteristics are 
displayed in Table 3. The majority of primary caregivers identified as biological mothers (84%). Primary 
caregivers ranged in age from 33 to 69 years (M = 46.22, SD = 6.29) and were primarily Caucasian 
(97.5%), married (88.9%), well-educated (46.9% had at least a 4-year college degree), and employed at 
least part-time (77.8%). More than half (59%) of the caregivers reported family earnings of at least $80,000 
per year.   
 Descriptive statistics for adolescent participants are displayed in Table 4. Approximately half the 
sample consisted of male (49.4%) and female (48.1%) adolescents, with an additional two adolescents 
identifying as transgender or other (2.4%). Adolescents ranged in age from 12 to 17 years (M = 15.17, SD = 
1.72). The majority of adolescents identified as Caucasian (95.1%). Most recent HbA1c varied from 5% to 
14% (M = 8.5, SD = 1.76), with higher scores representing poorer metabolic control. Nearly a third of 
adolescents (31%) were in good metabolic control (i.e., HbA1c < 7.5%). Adolescents’ mean age at 
diagnosis was 10.56 years of age (SD = 3.38), and the mean length of diagnosis was 4.62 years (SD = 2.99). 
Over half of the adolescents reported dosing and administering their insulin via pump (56.8%), and nearly 
one-third of adolescents utilized a continuous blood glucose monitor (32.1%). 
 Descriptive data for aspects of sleep quality, caregiver- and adolescent-reported adherence to 





Table 3. Primary Caregiver Demographic and Household Characteristics (N = 81) 
 
 n % Mean SD Range 
Age (years)   46.22 6.29 33-69 
Relationship to Adolescent      
Biological Mother 68 84    
Biological Father 10 12.3    
Adoptive Mother 1 1.2    
Grandmother 1 1.2    
Race/Ethnicity      
Caucasian 79 97.5    
Latino/Hispanic 1 1.2    
Asian/Pacific Islander 1 1.2    
Marital Status      
Married/Living with Partner 72 88.9    
Single/Never Married 4 4.9    
Divorced  2 2.5    
Separated 2 2.5    
Widowed 1 1.2    
Education      
Partial High School 2 2.5    
High School/GED 9 11.1    
Partial College  
(at least 1 year) 
15 18.5    
Associates Degree 17 21.0    
≥ 4-year College Degree 38 46.9    
Occupational Status      
Employed Full Time 40 49.4    
Employed Part Time 23 28.4    
Unemployed 10 12.3    
Retired 1 1.2    
Not Working/Disabled 5 6.2    
Student 2 2.5    
Number of People in Household   4.68 1.29 2-9 
Number of Siblings   2.01 1.46 0-10 
Family Income      
≤ $20,000 4 4.9    
$20,000 – 49,000 7 8.6    
$50,000 – 79,000 20 24.7    
$80,000 – 109,999 16 19.8    
$110,000 – 139,999 9 11.1    
$140,000 – 169,999 10 12.3    
≥ $170,000 12 15.8    
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Table 4. Adolescent Demographic Characteristics (N = 81) 
   
 n % Mean SD Range 
Age (years)   15.17 1.72 12.03-17.98 
Gender      
Female 39 48.1    
Male 40 49.4    
Transgender 1 1.2    
Other 1 1.2    
Grade   9.35 1.74 6th-13th 
Race/Ethnicity       
Caucasian 77 95.1    
Latino/Hispanic 2 2.5    
African American 1 1.2    
Biracial 1 1.2    
Diabetes Related Information       
Age at Diagnosis (years)   10.56 3.38 1.68-16.86 
Length of Diagnosis (years)   4.62 2.99 1.10-13.76 
Most recent HbA1C value   8.50 1.76 5.00-14.00 
Adolescents who receive insulin 
via pump 46 56.8    
Adolescents who use continuous 
blood glucose monitor 26 32.1    
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functioning are presented in Table 5. Approximately 9% and 24% of adolescents reported borderline to 
clinically significant levels of depression and anxiety, respectively. Notably, nine families were contacted 
because of concerns on self-report measures of symptoms of depression. Nearly 10% of adolescents and 
16% of caregivers reported borderline to clinically significant concerns regarding global executive 
functioning.  
 A total of 51 adolescents completed a 5-night sleep diary. A series to t-tests, chi-squares, and 
Mann-Whitney U tests were conducted to examine differences in adolescents who did and did not complete 
sleep diaries. Adolescents who completed sleep diaries reported better adherence to diabetes management 
tasks than those who did not, t(49.57) = -2.03, p< .05. A chi-square test (χ2) demonstrated a significant 
relationship between sleep diary completion and caregiver employment status, χ2(1, N = 81) = 4.12, p < 
.05. The odds of adolescents completing a sleep diary were 0.27 times higher if the participating caregiver 
was employed than if they were unemployed. Adolescents who completed sleep diaries did not 
significantly differ from adolescents who did not complete sleep diaries on other variables of interest.  
 On average, adolescents obtained approximately 8 hours and 18 minutes (SD = 1:09, range = 4:53 
– 11:02) of sleep across five nights. There was a significant difference in the amount of sleep adolescents 
obtained on weekends (M = 8:42, SD = 1:31) compared to weekdays (M = 8:10, SD = 1:21), t(44) = -2.02, p 
< .05 (see Table 6). In the current study, 43% of 12-13 and 57% of 14-17 year olds reported obtaining the 
recommended amount of sleep for their age group (Overall TST). Approximately 36% of 12-13 and 43% of 
14-17 year olds obtained the recommended amount of sleep for their age on weekdays. Nearly 42% of 12-
13 and 70% of 14-17 year olds obtained the recommended amount of sleep for their age on weekends. The 
National Sleep Foundation recommends adolescents ages 12-13 obtain 9-11 hours of sleep per night and 
adolescents ages 14-17 obtain 8-10 hours of sleep per night (Hirshkowitz et al., 2015). Nearly 32% of all 
adolescents in the current study reported obtaining less than 8 hours of sleep over the course of five nights. 
Among participants ages 12-13, approximately 7% of adolescents reported obtaining less 8 hours of sleep 
on weekdays. This percentage increased to nearly 15% on weekends. Among 14-17 year olds, 
approximately 57% of adolescents reported obtaining less than 8 hours of sleep on weekdays. This 
decreased to approximately 27% on weekends (see Table 7). Bivariate correlations were performed to  
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Table 5. Means, Standard Deviations, and Ranges for Adolescent- and Caregiver-Report 
Measures (N = 81) 
 
Variable Mean SD Range 
Daytime Sleepiness (CASQ)  32.82 9.79 16-66 
Sleep Quality (ASWS) 4.24 0.72 2.5-5.81 
Internalizing Symptoms (BASC2 SRP-A; T-scores)    
Anxiety 50.26 12.27 30-87 
Depression 46.83 9.55 39-89 
Executive Functioning (BRIEF; T-score)    
Behavioral Regulation Index (BRI) 53.32 11.99 37-85 
Metacognition Index (MI) 51.56 10.91 37-79 
Global Executive Composite (GEC) 52.86 12.01 36-84 
Executive Functioning (BRIEF-SR; T-score)    
Behavioral Regulation Index (BRI)  48.88 9.84 33-82 
Metacognition Index (MI) 49.93 11.09 31-83 
Global Executive Composite (GEC) 49.48 10.74 30-85 
Treatment Adherence (SCI-R)    
Caregiver 71.93 11.26 45.00-91.67 





Table 6. Sleep Quantity Based on Five Night Sleep Diary (N = 51) 
 
 Mean SD Range 
Weekday Total Sleep Time 8:10 1:21 4:41-11:07 
Weekend Total Sleep Time 8:42 1:31 5:11-14:50 
Overall Total Sleep Time 8:18 1:09 4:53-11:02 
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Table 7. Percentage of Adolescents Obtaining Less Than 8 Hours of Sleep (N = 51) 
 
  Age Group 
 Overall 12-13 14-17 
Weekday Total Sleep Time 43.14 7.14 56.76 
Weekend Total Sleep Time 23.53 14.29 27.03 
Overall Total Sleep Time 31.37 0 43.24 
Note. 12-13 year olds (n = 14), 14-17 year olds (n = 37) 
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examine the relationship between age and sleep quantity. Increasing age was associated with less sleep 
overall, r = -.44, p < .01 and less weekday sleep, r = -.44, p < .01 (see Table 8).  
Preliminary Analyses 
 Preliminary analyses were conducted using parametric (i.e., t-test, Pearson correlation) and non-
parametric (i.e., Spearman rho and Mann-Whitney U Test) statistical analyses to examine potential 
relationships among demographic characteristics (e.g. age, adolescent race/ethnicity, income), diabetes-
related characteristics (e.g. most recent HbA1c, treatment adherence, length of diagnosis, type of insulin 
administration), and study variables (e.g., sleep quality and quantity, executive functioning, anxiety, and 
depression) in order to identify potential covariates. There were two general demographic covariates (i.e., 
adolescent and caregiver age) and two diabetes-related covariate (i.e., length of diagnosis and insulin pump 
status) that were associated with constructs of interest.  
 Demographic covariates.  
 Age. Adolescent age was significantly associated with adolescent-reported daytime sleepiness, r = 
.29, p < .01, anxiety, r = .30 p < .01, executive functioning, r = .23, p < .05, and adherence, r = -.36, p < 
.001. Due to significant skew and kurtosis of adolescent-reported depression, Spearman rho correlations 
were performed to examine the relationship between symptoms of depression and variables of interest. Age 
was significantly associated with adolescent-reported depression, Spearman rho = .35, p < .01. Regarding 
adolescent-reported total sleep time, age was significantly associated with overall total sleep time, r = -44, 
p < .01, and average weekday sleep time, r = -.44, p < .01. 
 Caregiver age. Caregiver age was significantly associated with adolescent overall total sleep time, 
r = -.34, p < .05, and average weekday sleep time, r = -.32, p < .05. Caregiver age was not associated with 
aspects of adolescent-reported internalizing symptoms or parent- and adolescent-reported executive 
functioning, adherence to diabetes management tasks, or metabolic control.  
 Diabetes-specific covariates. 
 Length of diagnosis. Length of diagnosis was significantly associated with metabolic control, r = 
.23, p < .05, such that longer diagnosis was associated with poorer metabolic control. Length of diagnosis 
was also significantly associated with overall total sleep time, r = -.31, p < .05.  
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Table 8. Pearson Correlations of Adolescent Age and Total Sleep Time Variables (N = 51) 
Variable Age 
Weekday Total Sleep Time -.44** 
Weekend Total Sleep Time   -.13 
Overall Total Sleep Time -.44** 
Note. *p < .05. **p < .01. ***p < .001. 
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Insulin pump status. Analyses revealed significant differences in adolescent-reported anxiety 
when comparing participants’ method of insulin administration. Adolescents who reported use of an insulin 
pump reported greater symptoms of anxiety (M = 54.54, SD = 12.75) than adolescents who use daily 
insulin injections (M = 44.63, SD = 9.03), t(78.65) = - 4.10, p < .001.  
 Correlations between adherence and metabolic control. Unlike previous research, which has 
generally found an association between treatment adherence and metabolic control, neither caregivers’, r = 
-.11, ns, nor adolescents’, r = -.18, ns, reports of adolescents’ treatment adherence were significantly 
related to most recent HbA1c values. There was a moderate level of agreement between caregiver and 
adolescent reports of adolescent treatment adherence as measured by the SCI-R, r = .62, p < .001.  
 Correlations among measures of aspects of sleep quality and quantity. Relationships among 
adolescent-reported sleep quality, daytime sleepiness, and total sleep time (overall, weekdays, and 
weekends) were examined utilizing Pearson correlations. Sleep quality was significantly associated with 
overall total sleep time, r = .30, p < .05, and weekday total sleep time, r = .34, p < .05. Better adolescent-
reported sleep quality was associated with more overall and weekday sleep. Daytime sleepiness was 
negatively associated with overall total sleep time, r = -.31, p < .05, and weekday total sleep time, r = -.34, 
p < .05. Greater daytime sleepiness was associated with less overall and weekday total sleep time. Analyses 
revealed no statistically significant relationships among weekend total sleep time, sleep quality, and 
daytime sleepiness. The correlations for measures of sleep quality and quantity are presented in Table 9.  
Hypotheses 1-4: Associations Among Adolescent-Reported Sleep Quality, Sleep Quantity, and 
Adolescent- and Caregiver-Reported Adherence to Diabetes Regimen and Metabolic Control  
 To examine associations among the first set of hypotheses, bivariate correlations were examined 
among adolescents’ sleep quality and quantity variables, treatment adherence (as measured by caregiver 
and adolescent report), and metabolic control (as measured by adolescents’ most recent HbA1c values).  
 Associations among adolescent-reported sleep quality, daytime sleepiness, adherence, and 
metabolic control.  
 Sleep Quality. Bivariate associations among sleep quality variables, as measured by adolescent-
reported sleep quality, daytime sleepiness, treatment adherence, and metabolic control are presented in 
Table 10. There were several significant associations among variables of interest. Daytime sleepiness was  
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Table 9. Pearson Correlations of Adolescent-Report Measures of Sleep Quality and Quantity (N = 51) 
Variable Sleep Quality (ASWS) Daytime Sleepiness (CASQ) 
Weekday Total Sleep Time .34* -.34* 
Weekend Total Sleep Time  .05 -.05 
Overall Total Sleep Time .30* -.31* 
Note. *p < .05.  
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significantly associated with both caregiver reports, r = -.33, p < .01, one-tailed, and adolescent reports, r = 
-.52, p < .001, one-tailed, of adolescent treatment adherence. Specifically, greater daytime sleepiness was 
associated with poorer adherence to diabetes management tasks. Sleep quality was also significantly 
associated with both caregiver-, r = .30, p < .01, one-tailed, and adolescent- r = .38, p < .001, one-tailed, 
reported adolescent treatment adherence, such that poorer sleep quality was associated with poorer 
adolescent adherence to diabetes management tasks. Bivariate correlations revealed that there were no 
significant associations between metabolic control, daytime sleepiness, or sleep quality.  
 Sleep Quantity. Bivariate associations among sleep quantity variables, as measured by overall 
total sleep time, weekday total sleep time, and weekend total sleep time and treatment adherence and 
metabolic control are presented in Table 11. The only significant association observed among variables of 
interest was weekend total sleep time and caregiver-reported adolescent adherence to diabetes management 
tasks, r = -.26, p < .05. Greater weekend total sleep time was associated with poorer caregiver-reported 
adolescent treatment adherence. Metabolic control was not associated with sleep quantity.  
Hypotheses 5-8: Mediation of Aspects of Sleep and T1DM-Related Outcomes by Internalizing 
Symptoms and Neurocognitive Functioning  
 Mediation analyses were used to determine if variables assessing adolescent-reported internalizing 
symptoms (i.e., anxiety and depression) and caregiver- and adolescent-reported neurocognitive functioning 
(i.e., global executive functioning) served as mediators to the relationships between adolescents’ sleep 
quality (i.e., sleep quality and daytime sleepiness) and T1DM-related outcomes (i.e., treatment adherence 
and metabolic control). Several mediation models were examined to assess caregiver- and adolescent-
reported measures of aforementioned constructs. Mediation models involving the prediction of metabolic 
control were not analyzed due to lack of significant associations among constructs of interest (i.e., 
adolescent-reported anxiety and depression, and caregiver- and adolescent-reported executive functioning) 
at the bivariate level (see Table 10). 
 Parallel multiple mediation of adolescent-reported sleep quality, daytime sleepiness, and 
treatment adherence through executive functioning, anxiety, and depression. For the present study, the 
first parallel multiple mediation model collapsed hypotheses 5 and 6 in order to examine if adolescent-
reported executive functioning, anxiety, and depression mediated the relationship between adolescents’  
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Table 10. Pearson Correlations of Adolescent-Report Measures of Sleep Quality, Adherence, and 
Metabolic Control (N = 81) 
   
Variable Sleep Quality (ASWS) Daytime Sleepiness (CASQ) 
Treatment Adherence (SCI-R)   
Caregiver .30** -.33** 
Adolescent .38*** -.52*** 
HbA1c -.08 .07 













Treatment Adherence (SCI-R)    
Caregiver -.01 .08 -.26* 
Adolescent .12 .13 .00 
HbA1c .01 .10 -.20 
Note. *p < .05.   
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sleep quality, daytime sleepiness, and adolescent-reported treatment adherence. Parallel multiple mediation 
models were run separately for sleep quality (ASWS) and daytime sleepiness (CASQ).  
 Sleep quality. Sleep quality was entered as the predictor variable (X), adolescent-reported 
treatment adherence was entered as the outcome variable (Y), and adolescent-reported anxiety (M1), 
depression (M2), and executive functioning (M3) were entered as mediators. Adolescents’ age and insulin 
pump status were entered as covariates.  
 Results examining parallel multiple mediation demonstrated that adolescent-reported anxiety, 
depression, and executive functioning significantly mediated the association between sleep quality and 
adherence to diabetes management tasks. Results of the final model are presented in Table 12 and Figure 6. 
 Sleep quality had a significant indirect effect on treatment adherence through its effect on anxiety, 
while holding all other mediators constant. Participants who reported poorer sleep quality reported higher 
levels of anxiety (a = -4.63), and participants who reported higher levels of anxiety reported better 
adherence to diabetes management tasks (b = .39). A bias-corrected bootstrap confidence interval for the 
indirect effect (ab = -1.82) was entirely below zero, bootstrap 95% CI [-4.49 to -.41], indicating a 
significant indirect effect of sleep quality on adherence through level of anxiety.  
 Similarly, sleep quality was observed to indirectly influenced treatment adherence through its 
effects on depression, while controlling for other mediators. Adolescents who reported poorer sleep quality 
reported higher levels of depression (a = -4.91), and adolescents who reported higher levels of depression 
reported poorer adherence to diabetes management tasks (b = -.38). The bias-corrected bootstrap 
confidence interval for indirect effects for sleep quality and depression (ab = 1.84) was entirely above zero, 
bootstrap 95% CI [.24 to 3.91], indicating a significant indirect effect of sleep quality on adherence through 
level of depression.  
 Executive functioning was also found to significantly mediate the relationship between sleep 
quality and treatment adherence, while holding all other mediators constant. Adolescents who reported 
poorer sleep quality reported greater difficulties with executive functioning (a = -7.5) and adolescents who 
reported greater difficulties with executive functioning reported poorer adherence to diabetes management 






Table 12. Regression Coefficients, Standard Errors, and Model Summary Information for the Sleep Quality Parallel Multiple Mediation Model Depicted in 
Figure 6  
 
  Consequent 
  M1 (Anxiety)   M2 (Depression)  M3 (GEC)  Y (Adherence) 
Antecedent  b SE p   b SE p   b SE p   b SE p 
X (Sleep Quality) a1 -4.63 1.44 .002  a2 -4.91 1.04 <.001  a2 -7.50 1.47 <.001  c’ 3.37 1.99 .10 
M1 (Anxiety)  - - -            b1 .39 .20 .05 
M2 (Depression)  - - -            b2 -.38 .19 .05 
M3 (GEC)  - - -            b3 -.34 .17 .05 
Constant im1 29.16 13.97 .04  im2 44.36 9.39 <.001  im3 66.25 11.84 <.001  iY .39 .20 .05 
R2  .37      .30     .31  .39 
F   19.09***  12.54*** 10.39***  6.84*** 
Note.  Controlling for adolescent age and insulin pump status, GEC = Global Executive Composite  






Figure 6. Parallel multiple mediation model examining the relationship between adolescent-reported sleep 
quality and adherence through anxiety, depression, and executive functioning (GEC) 
*p < .05. **p < .01. ***p < .001. 
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executive functioning (ab = 2.52) was entirely above zero, bootstrap 95% CI [.12 to 4.99], indicating a 
significant indirect effect of sleep quality on adherence through executive functioning.  
 With regard to the overall parallel multiple mediation model, there was no evidence that sleep 
quality influenced treatment adherence independent of its effects on anxiety, depression, and executive 
functioning (c’ = 3.37, ns). 
 Daytime sleepiness. A second parallel multiple mediation analysis examined the prediction of 
treatment adherence based on daytime sleepiness through internalizing symptoms and neurocognitive 
functioning. Daytime sleepiness was entered as the predictor variable (X), adolescent-reported treatment 
adherence was entered as the outcome variable (Y), and adolescent-reported anxiety (M1), depression (M2), 
and executive functioning (M3) were entered as mediators. Adolescent age and insulin pump status were 
entered as covariates. Results of the final model are presented in Table 13 and Figure 7. 
 Results examining parallel multiple mediation demonstrated that only adolescent-reported anxiety 
significantly mediated the association between daytime sleepiness and adherence to diabetes management 
tasks. Daytime sleepiness had a significant indirect effect on treatment adherence through its effect on 
anxiety, while holding all other mediators constant. Participants who reported more daytime sleepiness 
reported higher levels of anxiety (a = .29), and participants who reported higher levels of anxiety reported 
better adherence to diabetes management tasks (b = .36). A bias-corrected bootstrap confidence interval for 
the indirect effect (ab = .10) was entirely above zero, bootstrap 95% CI [.001 to .31], indicating a 
significant indirect effect of sleep quality on adherence through level of anxiety.  
 Level of depression and executive functioning did not significantly mediate the relationship 
between daytime sleepiness and treatment adherence (see Table 13). With regard to the overall parallel 
multiple mediation model, there was evidence that daytime sleepiness influenced treatment adherence 
independent of its effects on anxiety, depression, and executive functioning (c’ = -.41 p < .01), such that 
greater daytime sleepiness predicted poorer adherence to diabetes management tasks. 
 Simple mediation of adolescent-reported sleep quality, daytime sleepiness, caregiver-
reported adolescent treatment adherence through caregiver-reported executive functioning. Two 







Table 13. Regression Coefficients, Standard Errors, and Model Summary Information for the Daytime Sleepiness Parallel Multiple Mediation Model Depicted 
in Figure 7.  
   
  Consequent 
  M1 (Anxiety)   M2 (Depression)  M3 (GEC)  Y (Adherence) 
Antecedent  b SE p   b SE p   b SE p   b SE p 
X (Daytime 
Sleepiness) a1 .29 .14 <.001  a2 .42 .09 <.001  a2 .62 .11 <.001  c’ -.41 .16 .01 
M1 (Anxiety)                b1 .36 .21 .09 
M2 (Depression)                b2 -.31 .18 .10 
M3 (GEC)                b3 -.26 .17 .12 
Constant im1 1.62 10.96 .88  im2 14.60 6.99 .04  im3 20.89 9.82 .04  iY 122.79 10.87 .05 
R2  .35 .34 .36  .33 
F   17.07*** 11.93*** 14.89***  15.15*** 
Note.  Controlling for adolescent age and insulin pump status, GEC = Global Executive Composite 






Figure 7. Parallel multiple mediation model examining the relationship between adolescent-reported 
daytime sleepiness and adherence through anxiety, depression, and executive functioning (GEC) 






sleepiness predicted caregiver-reported adolescent treatment adherence through caregiver-reported 
executive functioning. 
 Sleep quality. Results of the first simple mediation model examining the relationship between 
adolescent-reported sleep quality and caregiver-reported treatment adherence through caregiver-reported 
adolescent executive functioning was significant. Sleep quality was found to indirectly predict caregiver-
reported adolescent treatment adherence through caregiver-reported adolescent executive functioning. 
Greater adolescent-reported sleep quality predicted better executive functioning (a = -4.11) and, in turn, 
better executive functioning predicted better caregiver-reported adolescent adherence to diabetes 
management tasks (b = -.43). A bias-corrected bootstrap confidence interval for the indirect effect (ab = 
1.78) was entirely above zero, bootstrap 95% CI [.34 to 3.83], indicating a significant indirect effect of 
sleep quality on adherence through executive functioning. Similar to the all adolescent-report model, there 
was no evidence that adolescent sleep quality influenced caregiver-reported adolescent adherence 
independent of its effect on caregiver perceptions of executive functioning (c’ = 2.88, ns).  Results of the 
final model are presented in Figure 8 and Table 14.  
 Daytime sleepiness. Results of the second simple mediation analysis demonstrated that caregiver-
reported adolescent executive functioning did not mediate the relationship between adolescent-reported 
daytime sleepiness and caregiver perspective of adolescent adherence to diabetes management tasks (a = 
.19, b = -.43, ab = -.08, bootstrap 95% CI [-.24 to .02]). A direct effect for adolescent-reported daytime 
sleepiness on caregiver-reported adolescent treatment adherence was observed (c’ = -.30, p < .01), such that 
greater daytime sleepiness predicted poorer adherence to diabetes management tasks. Results of the final 
model are presented in Figure 9 and Table 15. 
Hypotheses 9-12: Mediation of Sleep Quantity and T1DM-Related Outcomes by Internalizing 
Symptoms and Neurocognitive Functioning 
Although initially proposed, analyses examining if symptoms of anxiety and depression, as well as 
executive functioning mediated the relationship between sleep quantity and T1DM-related outcomes could 
not be performed due to limited sample size and power; estimations for mediation models could not be 





Table 14. Simple Mediation Model for Adolescent-Reported Sleep Quality Predicting Caregiver-Reported Adherence, Through Caregiver-Reported 
Executive Functioning, Depicted in Figure 8.  
   
  Consequent 
  M (GEC)  Y (Adherence) 
Antecedent  b SE p 95% CI   b SE p 95% CI 
X (Sleep Quality) a -4.11 1.80 .02 [-7.69, -.53]  c’ 2.88 1.80 .11 [-.70, 6.46] 
M (GEC)  - - - -  b -.43 .08 <.001 [-.60, -.27] 
Constant            
  R2 = .06     R2 = .29    
  F(1, 78) = 5.23, p =  .02    F(2, 77) = 18.80, p <.001  






Figure 8. Simple mediation model examining the relationship between adolescent-reported sleep quality 
and caregiver-reported adherence through caregiver-reported executive functioning (GEC) 









Table 15.  Simple Mediation Model for Adolescent-Reported Daytime Sleepiness Predicting Caregiver-Reported Adherence, Caregiver-Reported 
Executive Functioning, Depicted in Figure 9.  
   
  Consequent 
  M (GEC)  Y (Adherence) 
Antecedent  b SE p 95% CI   b SE p 95% CI 
X (Daytime Sleepiness) a .19 .16 .23 [-.13, .50]  c’ -.30 .11 .01 [-.52, -.08] 
M (GEC)  - - - -  b -.43 .08 <.001 [-.59, -.27] 
Constant            
  R2 = .02     R2 = .32    
  F(1, 77) = 1.40, p =  .24    F(2, 76) = 20.29, p <.001  






Figure 9. Simple mediation model examining the relationship between adolescent-reported daytime 
sleepiness and caregiver-reported adherence through caregiver-reported executive functioning (GEC) 




 Parallel multiple mediation examining adolescent reported anxiety, depression, and 
treatment adherence through sleep quality and daytime sleepiness.  Given the bidirectional nature of 
the relationship between sleep and internalizing symptoms (Moore & Meltzer, 2008; Moore et al., 2009), 
exploratory analyses were performed to examine alternative mediation models to determine if measures of 
sleep quality (i.e., sleep quality and daytime sleepiness) served as mediators to the relationship between 
internalizing symptoms (i.e., anxiety and depression) and adherence to diabetes management tasks. Two 
parallel multiple mediation models utilizing percentile bootstrap confidence intervals with 5,000 bootstraps 
were performed to examine measures of aforementioned constructs. Percentile bootstrap confidence 
intervals were utilized as bias-corrected bootstrapping resulted in unreliable estimates of indirect effects.   
 Anxiety. The first parallel multiple mediation analysis examined the prediction of adolescent-
reported treatment adherence based on anxiety through sleep quality and daytime sleepiness. Anxiety was 
entered as the predictor variable (X), adolescent-reported treatment adherence (SCI-R) was entered as the 
outcome variable, and sleep quality (M1) and daytime sleepiness (M2) were entered as mediators. 
Adolescent age and insulin pump status were entered as covariates. Results of the final model are presented 
in Figure 10 and Table 16. 
 Analyses showed that only daytime sleepiness significantly mediated the association between 
anxiety and adherence to diabetes management tasks. Anxiety had a significant indirect effect on treatment 
adherence through its effect on daytime sleepiness, while holding sleep quality constant. Participants who 
reported higher levels of anxiety reported greater difficulty with daytime sleepiness (a = .23). Adolescents 
who reported greater daytime sleepiness in turn reported poorer adherence to diabetes management tasks (b 
= -.54). A percentile bootstrap confidence interval for the indirect effect (ab = -.13) was entirely below 
zero, bootstrap 95% CI [-.33 to -.002], indicating a significant indirect effect of anxiety on adherence 
through daytime sleepiness.  
 Sleep quality did not significantly mediate the relationship between anxiety and adherence to 
diabetes management tasks. With regard to the overall parallel multiple mediation model, there was no 
evidence that anxiety influenced treatment adherence independent of its effects of daytime sleepiness (c’ = 





Table 16. Regression Coefficients, Standard Errors, and Model Summary Information for the Exploratory Anxiety Parallel Multiple Mediation 
Model Depicted in Figure 10.  
   
  Consequent 
  M1 (Sleep Quality)   M2 (Daytime Sleepiness)  Y (Adherence) 
Antecedent  b SE p   b SE p   b SE p 
X (Anxiety) a1 -.02 .01 .01  a2 .23 .13 .08  c’ .23 .17 .17 
M1 (Sleep Quality)  - - -   - - -  b1 3.18 2.00 .12 
M2 (Daytime Sleepiness)  - - -   - - -  b2 -.54 .19 .01 
Constant im1 5.72 .73 <.001  im2 4.30 8.34 .61  iY 94.70 15.03 <.001 
R2  .15   .16   .37 
F   4.38**  4.51**  8.47*** 
Note.  Controlling for adolescent age and insulin pump status 






Figure 10. Parallel multiple mediation model examining the relationship between adolescent-reported 
anxiety and adherence through sleep quality and daytime sleepiness 




Depression. A final parallel multiple mediation analysis was performed to examine whether the 
association between depression and adherence was mediated through sleep quality. Depression was entered 
as the independent variable (X), adolescent-reported adherence to diabetes management tasks was entered 
as the dependent variable (Y) and sleep quality (M1) and daytime sleepiness (M2) were entered as mediators. 
Age was entered as a covariate for the model. Results of the final model are presented in Figure 11 and 
Table 17.  
 Similar to the anxiety model, only daytime sleepiness significantly mediated the relationship 
between depression and treatment adherence. That is, depression had a significant indirect effect on 
adherence to diabetes management tasks through its effect on daytime sleepiness, while holding sleep 
quality constant. Participants who reported higher levels of depression reported greater daytime sleepiness 
(a = .55) and adolescents who reported greater daytime sleepiness reported poorer adherence to diabetes 
management tasks (b = -.43). A percentile bootstrap confidence interval for the indirect effect of anxiety 
through daytime sleepiness (ab = -.24) was entirely below zero, bootstrap 95% CI [-.50 to -.04]. Results 
suggest a significant indirect effect of depression on adherence through daytime sleepiness.  
  Sleep quality did not significantly mediate the relationship between depression and treatment 
adherence. There was no evidence that level of depression influenced treatment adherence independent of 





Table 17. Regression Coefficients, Standard Errors, and Model Summary Information for the Exploratory Depression Parallel Multiple 
Mediation Model Depicted in Figure 11.  
   
  Consequent 
  M1 (Sleep Quality)   M2 (Daytime Sleepiness)  Y (Adherence) 
Antecedent  b SE p   b SE p   b SE p 
X (Depression) a1 -.04 .01 .001  a2 .55 .14 <.001  c’ -.18 .14 .18 
M1 (Sleep Quality)  - - -   - - -  b1 1.63 1.89 .39 
M2 (Daytime Sleepiness)  - - -   - - -  b2 -.43 .17 .01 
Constant im1 6.20 .71 <.001  im2 -3.20 8.27 .70  iY 110.93 15.52 <.001 
R2  .22   .31   .34 
F   7.65***  11.75***  11.85*** 
Note.  Controlling for adolescent age and insulin pump status 






Figure 11. Parallel multiple mediation model examining the relationship between adolescent-reported 
depression and adherence through sleep quality and daytime sleepiness 






 The current study is the first to explore adolescent-reported sleep quality and daytime sleepiness as 
it relates to T1DM-related outcomes (i.e., treatment adherence and metabolic control) utilizing validated 
and reliable self-report measures of sleep quality and adolescent-reported adherence behaviors in the same 
study. This study also examines relationships among adolescent-reported sleep quantity and T1DM-related 
outcomes of interest. Furthermore, the present study is the first to consider whether aspects of sleep quality 
predict T1DM-related outcomes through internalizing symptoms and neurocognitive functioning. Results 
partially supported our hypotheses. As predicted, poorer sleep quality and greater daytime sleepiness were 
associated with poorer adherence to diabetes management tasks. Although we initially hypothesized that 
poorer sleep quality and greater daytime sleepiness would be associated with poorer metabolic control, this 
hypothesis was not supported. Few associations were observed among aspects of sleep quantity (i.e., 
average weekday, weekend, and overall sleep across five-nights of sleep), adherence, and metabolic 
control. Results of mediation analyses suggest sleep quality indirectly affects treatment adherence through 
anxiety, depression, and executive functioning. In contrast, daytime sleepiness predicts adherence directly, 
as well as indirectly through anxiety. Although initially proposed, mediation models examining the 
prediction of metabolic control were not performed due to lack of significant associations among constructs 
of interest at the bivariate level. Additionally, analyses examining if anxiety, depression, and executive 
functioning mediated the relationship between sleep quantity and T1DM-related outcomes were not 
performed due to limited sample size and power. Results of exploratory mediation analyses suggests both 
anxiety and depression predict adherence to diabetes management tasks through daytime sleepiness and not 
sleep quality.  
Relationships Among Aspects of Adolescents’ Sleep Quality, Sleep Quantity, and Illness Management  
Sleep quality, daytime sleepiness, and adherence. The first hypothesis explored associations 
among adolescents’ sleep quality, daytime sleepiness, and treatment adherence. Sleep quality and daytime 
sleepiness were assessed with adolescent-report measures. Adherence was assessed using caregiver- and 
adolescent-report measures. Results demonstrated significant associations among adolescent-reported sleep 
quality, daytime sleepiness, and caregiver- and adolescent-reported adolescent treatment adherence, such 
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that poorer sleep quality and greater daytime sleepiness were associated with poorer caregiver- and 
adolescent-reported adherence to diabetes management tasks.  
To our knowledge, this is the first study to assess aspects of sleep quality and adherence utilizing 
validated and reliable adolescent-report measures in the same study. Previous research examining the 
association between sleep quality and adherence has yet to utilize validated and reliable adolescent-report 
measures of both constructs in the same study. Previous studies examining this relationship typically 
focused on objective measures of adherence (i.e., frequency of blood glucose checks, frequency of insulin 
boluses; Jaser et al. 2016; McDonough et al., 2017; Turner et al., 2016) or assessed adolescent sleep using 
parent-report measures (Hazen et al., 2015). Although blood glucose monitoring is pivotal to effective 
diabetes management, operationalization of adherence as the frequency of blood glucose checks or insulin 
boluses does not provide information regarding other adherence behaviors critical to illness management 
(Riekert & Rand, 2002). To date, only one study has examined the relationship between sleep quality and 
adolescent-report adherence using a valid and reliable measure of treatment adherence (i.e., SCI-R); 
however, adolescent sleep quality was assessed using parent-reports on four items from the Child Behavior 
Checklist (i.e., Hazen et al., 2015; see Table 1). Reliance on parent reports of adolescents’ sleep is 
problematic as caregivers are often unaware specific aspects of their child’s sleep, resulting in inaccurate 
estimation/portrayal of sleep (Sadeh, 1996; Werner, Molinari, Guyer, & Jenni, 2008). Furthermore, parental 
reports fail to reflect adolescents own subjective experience of their sleep.  
Sleep quality, daytime sleepiness, and metabolic control. The second hypothesis explored 
associations among adolescent-reported sleep quality, daytime sleepiness, and metabolic control. Sleep 
quality and daytime sleepiness were not significantly associated with most recent HbA1c values. Previous 
research examining the relationship between aspects of sleep quality and metabolic control in youth with 
T1DM is equivocal. The inconsistent relationship between sleep quality and metabolic control is likely a 
function differing methodologies (e.g., operationalization and measurement approach to sleep quality, age 
range of sample, and parent- versus adolescent-reported parameters) across a small number of studies 
examining these constructs. Results of a recent systematic review and meta-analysis examining associations 
among sleep characteristics and glycemic control in children and adults suggests adults with T1DM 
experience poorer sleep quality than healthy controls, particularly when assessed by questionnaire, but not 
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when assessed using objective measures of sleep (i.e., PSG; Reutrakul et al., 2016). Based on analyses 
performed as a part of this meta-analysis, Reutrakul and colleagues (2016) found that adults with T1DM 
who reported good sleep quality had significantly lower HbA1c scores by nearly 0.2% compared to adults 
who reported poor sleep quality. Similar analyses could not be performed on research examining sleep 
quality and metabolic control in youth with T1DM due to the limited data and number of published studies 
available for analysis.  
Sleep quantity and adherence. The third hypothesis examined the association between 
adolescent-reported sleep quantity (based on a five-night sleep diary) and adherence to diabetes 
management tasks. Specifically, analyses examined relationships among adolescent-reported average 
overall, weekday, and weekend sleep time and caregiver- and adolescent-reported treatment adherence. 
Few associations among variables of interest were observed. The current study found that greater weekend 
sleep was associated with poorer caregiver-reported adolescent adherence to diabetes management 
regimen. Sleeping more on weekends may represent adolescents’ attempt to address sleep debt 
accumulated throughout the week (Owens, 2014), resulting in an irregular sleep pattern known as oversleep 
(i.e., the difference in obtained weekday and weekend sleep; Owens, 2014). Although sleeping in on 
weekends provides some temporary relief from daytime sleepiness associated with insufficient weekday 
sleep, weekend oversleep may lead to disrupted sleep-wake cycles, exacerbation of normal circadian phase 
delay, and may lead to further difficulties with weekday alertness (Owens, 2014). Furthermore, there are 
several psychosocial consequences associated with oversleep and sleep loss that may have real-world 
consequences, including depressed mood (Moore et al., 2009), decreased judgement, decreased motivation, 
inattention, and affective dysregulation (Owens, 2014), which may negatively impact diabetes 
management.  
Research examining the relationship between sleep duration and adherence is inconsistent. 
Previous research has demonstrated a negative relationship between sleeping more and poorer treatment 
adherence, specifically with regards to decreased frequency of blood glucose checks, implying adolescents 
may be asleep at times when diabetes cares are required (Hazen et al., 2015). Notably, generalizability of 
these findings is likely limited by sampling characteristics (i.e., adolescents specifically with poorly 
controlled diabetes) and reliance on secondary reports of adolescent sleep (i.e., parent reports; McDonough 
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et al., 2017). More recent research examining the relationship between sleep quantity and adherence has 
utilized adolescents’ reports of their own sleep quantity using a 14-night sleep diary and found that longer 
sleep duration was associated with better adherence (i.e., more frequent blood glucose checks and daily 
insulin boluses; McDonough et al., 2017). This is inconsistent with findings of the current study, which 
suggest longer sleep duration, especially on weekends, is associated with poorer treatment adherence. 
Inconsistent findings may be associated with differing operationalization and measurement used to assess 
adherence, as well as length of sleep diary (i.e., five- versus 14-nights).   
Sleep quantity and metabolic control. The fourth hypothesis examined the relationship between 
adolescent-reported sleep quantity (based on a five-night sleep diary) and metabolic control. Specifically, 
analyses examined relationships among adolescent-reported average overall, weekday, and weekend sleep 
time and most recent HbA1c value. In general, estimates of sleep quantity were not significantly associated 
with metabolic control. Limited research has assessed the relationship between sleep duration and 
metabolic control among individuals with T1DM. In a study examining the impact of sleep on academic 
functioning in youth with T1DM, HbA1c was significantly associated with adolescents’ estimates of their 
average sleep time, such that less total sleep time was associated with poorer metabolic control (Perfect, 
2014). The association between sleep duration and metabolic control in adolescents with T1DM is 
equivocal given the paucity of published research examining this relationship. Further, few studies have 
explored underlying mechanisms associated with the relationship between sleep and glycemic control 
(Farabi, 2016). Among healthy adults, research has shown that sleep disruption is associated with increased 
insulin resistance (Tasali et al., 2008). Among individuals with T1DM, Donga and colleagues (2010) found 
decreased insulin sensitivity after a single night of partial sleep restriction (i.e., four hours of sleep) versus a 
“normal” night of sleep (i.e., eight hours of sleep). Difficulties with insulin resistance may be compounded 
in adolescents with T1DM due to physiological changes associated with puberty (i.e., increased growth 
hormone resulting in increased insulin resistance). The relationship between sleep and glycemic control is 
further complicated by the effects of the “dawn phenomenon,” which impacts approximately half of all 
individuals with T1DM, and may partially explain the need for increased insulin during adolescents 
(Carroll & Schade, 2005). Although an association between sleep duration and glycemic control was not 
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observed in the current study, there is emerging evidence to suggest sleep disruption, which are commonly 
observed during adolescents, may impact metabolic control through insulin resistance.  
Mediations Models Predicting Treatment Adherence  
A primary contribution of the present study has been to explore the potential influence of 
internalizing symptoms and neurocognitive functioning on the relationship between sleep and T1DM-
related outcomes. The fifth and sixth hypotheses examined several models assessing the relationships 
between aspects of adolescent sleep quality and treatment adherence through symptoms of anxiety, 
depression, and executive functioning. Statistical analyses were performed using parallel multiple 
mediation for adolescent reports, which allowed for simultaneous testing of multiple mediators; thus, 
combining proposed analyses for the fifth and sixth hypothesis. Simple mediation analyses were performed 
to examine the relationship between aspects of adolescent-reported sleep quality and caregiver-reported 
adolescent treatment adherence through caregiver-reported adolescent executive functioning (BRIEF 
GEC).   
Sleep quality. As predicted, mediation analyses indicated that the relationship between sleep 
quality and treatment adherence was influenced indirectly by internalizing symptoms and executive 
functioning. The simple mediation model examining caregiver-reported adolescent executive functioning 
and treatment adherence was consistent with results of the parallel multiple mediation model. Sleep quality 
did not directly predict treatment adherence after accounting for the influence of the mediators, suggesting 
the relationship between sleep quality and adherence to diabetes management tasks is fully mediated by 
symptoms of anxiety and depression and executive functioning abilities.  
In the current study, results showed that poorer sleep quality predicts higher levels of anxiety, 
which in turn predicts better treatment adherence, suggesting that anxiety may act in a protective manner to 
support adherence. The direction of the relationship between sleep quality and adherence through anxiety is 
unexpected and inconsistent with previous research, which has shown a negative linear relationship 
between anxiety and frequency of blood glucose checks (i.e., as anxiety increases, blood glucose 
monitoring decreases; Herzer & Hood, 2010). Although Herzer and Hood (2010) suggest that there may be 
no “optimal” level of anxiety for promoting adherence, results of the current study indicate that increased 
levels of anxiety may help promote general adherence among adolescents experiencing better sleep quality.  
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One possible explanation for the current findings is that adolescence who experience better sleep 
quality, and therefore less anxiety, may be less motivated to engage in management behaviors. It also 
possible that adolescents who experience better sleep quality may be less vigilant to physiological 
symptoms associated with glycemic excursions (e.g., hyper- or hypoglycemia) and are therefore less likely 
to engage in management behaviors. The reverse may also be true, in which adolescents who experience 
poorer sleep quality may be more vigilant or sensitive to physiological cues associated with diabetes, and 
they are therefore more likely to engage in adherence behaviors.  
Another possible explanation for the unexpected pattern of results is that the relationship between 
anxiety and treatment adherence may change from a linear to quadratic relationship with the addition of 
sleep quality. Furthermore, the observed relationship between sleep quality and adherence through anxiety 
may have been impacted by the relatively low (i.e., non-clinical) level of anxiety symptomatology in the 
current sample. Additional research examining the relationship between sleep quality and adherence among 
adolescents experiencing clinical levels of anxiety is needed. Finally, given the overlap between anxiety 
and other internalizing symptoms (e.g., depression, somatization), it is unclear to what extent results of the 
current study may be attributed to the shared variance associated with internalizing symptoms in general or 
to the unique variance associated with anxiety. Additional research is needed to better understand the 
unique quality of anxiety that may impact the relationship between sleep quality and adherence in 
adolescents with T1DM (e.g., fear of hypoglycemia, restlessness or feeling on edge).  
Results also demonstrated that the relationship between sleep quality and adherence to diabetes 
management tasks was influenced indirectly by symptoms of depression. Poorer sleep quality predicted 
greater symptoms of depression, which in turn predicted poorer treatment adherence. These findings are 
consistent with previous research demonstrating that poorer sleep quality is associated with elevated rates 
of depressive symptoms (Morrison et al., 1992; Roberts et al., 2001) and that depressive symptoms are 
associated with poorer adherence behaviors in youth with T1DM (Hood et al., 2006). Extant literature 
suggests symptoms of depression may negatively impact illness management through increased cognitive 
burden, which may serve to diminish adolescents’ ability to concentrate while engaging in management 
behaviors (Grey et al., 2002; Hains et al., 2006; Herzer & Hood, 2010). Numerous symptoms of depression 
such as difficulty concentrating, remembering details, and decision-making; decreased motivation; and 
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withdrawal may further exacerbate difficulties associated with non-adherence (e.g., remembering to check 
blood glucose levels, accurately counting carbs, engaging in regular physical activity) typically observed 
during adolescence, resulting in even poorer adherence. Results underscore the importance of considering 
the impact of sleep quality on mood, which in turn may negatively impact treatment adherence in 
adolescents with T1DM. 
Results of analyses examining the relationship between sleep quality and caregiver- and 
adolescent-reported adherence through caregiver- and adolescent-reported adolescent executive functioning 
were consistent with the initial hypothesis. For both parallel multiple and simple mediation models, sleep 
quality was associated with adherence through executive functioning. Poorer sleep quality predicted greater 
executive dysfunction, which in turn predicted poorer adherence to diabetes management tasks. These 
findings are consistent with previous research examining the relationship between sleep quality and 
executive functioning, which showed that poorer sleep quality was associated with decreased cognitive and 
executive functioning in healthy adolescents (Beebe, 2011) and youth with T1DM (Caruso et al., 2014). 
Additionally, emerging evidence has demonstrated that greater executive dysfunction predicts poorer 
treatment adherence (McNally et al., 2010; Perez et al., 2017), regardless of age (Bagner et al., 2007). 
Research suggests executive dysfunction may negatively influence treatment adherence through decreased 
problem solving, self-monitoring, and working memory skills, which are critical to effective self-
management in T1DM (Bagner et al., 2007). Additionally, poorer executive functioning may impact illness 
management through specific EF skills, such as adolescents’ ability to hold a goal in mind, adjust and 
execute behaviors to obtain that goal, and attend to relevant information while simultaneously inhibiting 
non-relevant behavior that may otherwise detract from goal attainment. These skills likely underlie many 
critical illness-related care activities, such as remembering to check one’s blood glucose regularly, 
adjusting insulin dosage based on blood glucose monitoring, tracking carbohydrate intake, accounting for 
physical activity, and monitoring and addressing natural and unexpected fluctuations in blood glucose 
levels. Results highlight the importance of considering the impact of sleep quality on executive functioning 
abilities, which in turn may negatively impact adherence to diabetes management tasks in adolescents with 
T1DM.  
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While previous research has established the relationship between the presence of T1DM and 
executive functioning through sleep quality in youth (ages 6-16; Caruso et al., 2014), to our knowledge, 
this is the first study to explore the relationship between sleep quality and adherence through executive 
functioning in adolescents with T1DM. While results underscore the importance of considering the 
influence of executive functioning on the relationship between sleep quality and adherence, additional 
research is needed to better understand how sleep impacts executive functioning in this population and 
which specific aspects executive functioning are critical to effective diabetes management. 
Daytime sleepiness. Mediation analyses examining the relationship between daytime sleepiness 
and adherence were partially supported. Results indicated that the relationship between daytime sleepiness 
and treatment adherence was influenced indirectly by symptoms of anxiety and not depression or executive 
functioning. The simple mediation model examining caregiver-reported adolescent executive functioning 
and treatment adherence were consistent with results of the parallel multiple mediation model examining 
adolescent reports of constructs of interest. Daytime sleepiness was directly associated with caregiver- and 
adolescent-reported adherence after accounting for the influence of mediators in both models, suggesting 
the relationship between daytime sleepiness and adherence to diabetes management tasks is partially 
mediated by symptoms of anxiety. Similar to analyses examining the influence of anxiety on the 
relationship between sleep quality and adherence, results suggest that more daytime sleepiness predicts 
higher levels of anxiety, which in turn predicts better treatment adherence, again suggesting that anxiety 
may promote adherence in adolescents experiencing difficulties with daytime sleepiness.  
To our knowledge, this is the first study examining the relationship between daytime sleepiness 
and adherence in adolescents with T1DM. Results of mediation analyses suggest daytime sleepiness may 
be a good predictor of adherence to diabetes management tasks, above and beyond internalizing symptoms 
and executive functioning in adolescents with T1DM. Daytime sleepiness may affect adherence through 
other facets of daytime functioning not examined in the current study, such as problem-solving, attention, 
and memory; however, research examining the relationship between these constructs and daytime 
sleepiness is limited in pediatric populations (Fallone, Owens, & Deane, 2002). Although adolescents in the 
current study reported similar levels of daytime sleepiness as healthy adolescents (Spilsbury et al., 2007), 
results underscore the significant role daytime sleepiness may play in adolescents’ ability to effectively 
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adhere to diabetes management tasks. Given the limited research examining daytime sleepiness in 
adolescents with T1DM, additional research is critical better understand its effects on illness management.  
Exploratory Analyses  
 Given the bidirectional nature of the relationship between sleep and internalizing symptoms 
(Moore & Meltzer, 2008; Moore et al., 2009), exploratory analyses were performed to examine alternative 
mediation models to determine if measures of sleep quality (i.e., sleep quality and daytime sleepiness) 
served as mediators to the relationship between internalizing symptoms (i.e., anxiety and depression) and 
adherence to diabetes management tasks (adolescent reports only). Results of exploratory mediation 
analyses demonstrated that symptoms of anxiety and depression are indirectly associated with treatment 
adherence through daytime sleepiness and not sleep quality. The mediational role of daytime sleepiness and 
its negative relationship with adherence may help to explain the potential adverse impact of anxiety and 
depression on diabetes management among adolescents with T1DM. Adolescents experiencing increased 
symptoms of anxiety or depression may need more sleep than individuals with better psychological 
functioning or require more energy to cope with everyday challenges (Moore et al., 2009), including 
diabetes management. It is also possible that adolescents experiencing increased levels of internalizing 
symptoms may have more negative perceptions of their sleepiness (Moore et al., 2009) and adherence 
behaviors.  
Sleep Quantity in Adolescents with T1DM 
 In the present study, adolescents obtained an average of 8 hours and 18 minutes (i.e., 8.3 hours) of 
sleep over the course of five consecutive nights. Adolescents obtained significantly less sleep on weekdays 
(i.e., 8 hours and 10 minutes) than on weekends (i.e., 8 hours and 42 minutes). Observed sleep duration in 
the current study is somewhat lower than previously published research examining sleep in youth with 
T1DM. For example, based on four to six nights of sleep diary data, Perfect and colleagues (2014) found 
that average sleep duration for youth (ages 10-16) with T1DM was 8.76 hours. Similarly, based on 14 
nights of sleep diary data, McDonough and colleagues (2017) found that average sleep duration was 8.57 
hours among adolescents (ages 12-18) with T1DM.  
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Nearly 60% of 12-13 and 45% of 14-17 year olds obtained less than the recommended amount of 
sleep for their age (average overall TST; Hirshkowitz et al., 2015). Overall, nearly 32% of adolescents 
reported obtaining less than 8 hours of sleep on average across a five-night period. The percentage of 
adolescents who obtained less than the recommended amount of sleep increased across age groups (i.e., 12-
13 and 14-17 year olds). In general, lower rates of insufficient sleep were observed among adolescents ages 
12-13. The highest rates of insufficient sleep were observed among adolescents ages 14-17, in which nearly 
57% of adolescents reported obtaining less than 8 hours of sleep on weekdays. The overall rate of 
insufficient sleep on weekends was nearly 25%, while weekdays was approximately 43%. Rates of 
insufficient sleep in the present study are somewhat lower than previously reported. For example, in a 
nationally representative sample of high school students, Eaton and colleagues (2010) found that nearly 
69% of adolescents obtained less than 8 hours of sleep on school nights. This discrepancy may be 
associated with differences in measurement of sleep quantity used by Eaton and colleagues (2010) and the 
present study. Specifically, the current study assessed sleep quantity throughout the year (i.e., school year, 
summer break, holiday breaks) using a multi-night self-report sleep diary, whereas Eaton and colleagues 
(2010) quantified sleep duration by asking high school students to estimate the average amount of sleep 
they obtain on school nights. Response options included 4 hours or less, 5, 6, 7, 8, and 9 hours, or 10 hours 
or more.   
 Sleep duration may be overestimated in the present study. Research has demonstrated that sleep 
diaries may overestimate the amount of sleep adolescents obtain compared to actigraphic measures of sleep 
duration (Short, Gradisar, Lack, Wright, & Carskadon, 2012). Existing literature examining sleep duration 
in adolescents with T1DM suggests adolescents may overestimate the total amount of sleep obtained on 
self-report measures of sleep (e.g., sleep diaries, estimate of typical sleep duration on school and non-
school nights) compared to actigraphy (Perfect et al., 2014). Despite these limitations, sleep diaries are 
considered the gold standard for the subjective measurement of sleep (Carney et al., 2012). Compared to 
PSG and actigraphy, sleep diaries are easy to use, less expensive, and readily available (Tremaine et al., 
2010) to clinicians and clinical investigators, as well as the general population. Additionally, sleep diaries 
are simple to administer, score, and interpret. Although objective measures of sleep provide more reliable 
estimates of sleep duration (Buckhalt et al., 2009; Meltzer et al., 2012) than sleep diaries, interpretation of 
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PSG/actigraphy data in pediatric populations is limited by the lack of available age-appropriate norms 
(Griebel & Moyer, 2006; Meltzer et al., 2012).  
Sleep Quality in Adolescents with T1DM 
 In the present study, adolescent-reported sleep quality appears to be consistent with previous 
reports of sleep quality (utilizing the ASWS) among Israeli adolescents with T1DM (Adler et al., 2016), 
healthy adolescents (Murray, Murphy, Palermo, & Clarke, 2012; Palermo, Fonareva, & Janosy, 2008; 
Palermo, Wilson, Lewandowski, Toliver-Sokol, & Murray, 2011; Walker, Johnson, Miaskowski, Lee, & 
Gedaly-Duff, 2010; Zafar, Ness, Dowdy, Avis, & Bashir, 2012), those undergoing treatment for cancer 
(Walker et al., 2010), and adolescents with multiple sclerosis (Zafar et al., 2012). Furthermore, sleep 
quality among adolescents with T1DM appears to be better than sleep quality among adolescents with 
diagnosed depressive disorders (Murray et al., 2012), as well as adolescents with chronic pain conditions 
(Palermo et al., 2008; Palermo et al., 2011). Similarly, adolescents in the current study reported comparable 
levels of daytime sleepiness as adolescents without known sleep disorders (Spilsbury et al., 2007). Poorer 
sleep quality and greater daytime sleepiness were associated with less overall and weekday sleep, but not 
weekend sleep, which is consistent with previous research examining the relationship between sleep quality 
and sleep duration (as measured by sleep diaries) among healthy adolescents (Short et al., 2012).   
Adherence and Metabolic Control 
 Adolescent-reported adherence appears to be better than previously reported amongst adults with 
T1DM (Weinger et al., 2005). Adolescents demonstrated a broad range of metabolic control (i.e., from 5-
14%), with nearly a third of the sample in “good” metabolic control (i.e., <7.5%, ADA, 2017). Caregiver- 
and adolescent-reported adherence to diabetes management tasks were not significantly associated with 
most recent HbA1c. Although this is inconsistent with previous research (Weigner et al., 2005), the lack of 
relationship between adherence to diabetes management tasks and metabolic control may be a function of 
stress, metabolism (Gandhi, Vu, Eshtehardi, Wasserman, & Hilliard, 2015), and normal physiological 
changes associated with adolescents that are independent of adherence efforts (e.g., increased growth 
hormone, occurrence of the dawn phenomenon, and insulin resistance; Anderson et al., 1999; Carroll & 
Schade, 2005; Dabadghao et al., 2001; Moran, 2002; Wysocki et al., 2005). Furthermore, the lack of 
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association between HbA1c and adherence in the present study may also be associated with discrepant 
measurement time frames as adherence was assessed over the previous 2 weeks from date of participation, 
whereas most recent HbA1c value could have occurred up to 12 months prior to the date of participation. As 
such, for some adolescents, most recent adherence efforts may be discordant with previous adherence 
behaviors at the time of their most recent HbA1c assay.  
Clinical Implications 
 The present study findings have several potential clinical implications that may influence illness 
management among adolescents with T1DM. Although adolescents with T1DM appear to experience 
similar levels of sleep quality and daytime sleepiness as their otherwise healthy peers, the current study 
found that poorer sleep quality and daytime sleepiness are associated with poorer treatment adherence. 
Results suggest sleep quality predicts adherence through anxiety, depression, and executive functioning. 
Additionally, daytime sleepiness predicts treatment adherence directly and through anxiety. Further, 
exploratory analyses suggest anxiety and depression appear to impact treatment adherence through daytime 
sleepiness. Results of the current study highlight that it is important for diabetes providers to better 
understand how sleep may impact adolescents' ability to care for their diabetes. Providers should consider 
assessing sleep quality, daytime sleepiness, internalizing behaviors, and executive functioning to identify 
adolescents who may be at risk for poorer diabetes management and potential difficulties with glycemic 
control. In fact, as of 2017, the American Diabetes Association Standards of Care recommends providers 
assess sleep patterns and duration, as well as psychosocial functioning (e.g., symptoms of anxiety and 
depression) as part of comprehensive medical evaluations. It may be beneficial for clinics to consider 
utilizing brief assessment measures of sleep quality (e.g., ASWS or CASQ), internalizing symptoms, and 
executive functioning in the future. There are number of well-validated measures that can be used to assess 
youth’s perspective regarding sleep (see Lewandowski et al., 2011), internalizing symptoms (see Klein, 
Dougherty, & Olino, 2010; Silverman & Ollendick, 2010), and executive functioning (e.g., BRIEF and 
BRIEF-SR; Gioia et al., 2000; Guy et al., 2004).  
Diabetes care teams should consider providing education and counseling to adolescents regarding 
sleep hygiene and the importance of sleep for illness management and in general (Hazen et al., 2015; 
McDonough et al., 2017). Education and counseling could take place during regularly scheduled clinic 
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appointments and/or during period diabetes education classes. Based on emerging evidence of the 
relationship between sleep and diabetes management, there are new efforts to develop a clinically relevant 
sleep modification protocol for youth with T1DM (Perfect et al., 2016). Adolescents with T1DM 
experiencing sleep difficulties may benefit from support services focused on identifying and addressing 
barriers to sleep, as well as difficulties associated with internalizing behavior and executive functioning, 
which may negatively impact illness management.   
Limitations and Future Directions 
 Several aspects of the current study may limit the generalizability of the findings. One limitation 
of the study was the cross-sectional design, thus only providing data regarding sleep quality, anxiety, 
depression, executive functioning, and diabetes management from one point in time. Results generally 
provide information regarding relationships among constructs of interest, rather than demonstrate causal 
relationships. Given the paucity of research examining sleep in adolescents with T1DM, examining 
relationships longitudinally and with multiple methods (i.e., subject and objective measures of sleep, 
psychosocial functioning, and T1DM-related outcomes) will allow for a better understanding of complex 
relationships among sleep, internalizing symptoms, executive functioning, and T1DM-related outcomes. 
Examining constructs of interest over time may also further clarify the developmental course, determinants, 
and impact of sleep disturbances on mental health, cognitive functioning, and illness management in this 
population.   
 Although sleep quality is an accepted clinical construct, it represents a complex and multifaceted 
phenomenon that is not readily defined. Previously published research examining sleep quality in 
adolescents T1DM varies widely in terms of the operationalization of sleep quality. The operational 
definition used in the present study is not necessarily equivalent to the operationalization used in previously 
published research examining sleep quality in youth with T1DM (e.g., Caruso et al., 2014; Hazen et al., 
2015; Perfect et al., 2014; Pillar et al., 2003; Varni et al., 2009). For example, sleep quality has been 
operationalized as sleep disturbances (Caruso et al., 2014), alterations in sleep architecture (Pillar et al., 
2003), fatigue (Varni et al., 2009), and sleep hygiene/habits (Perfect et al., 2014). Additionally, research is 
highly variable in terms of measurement of sleep quality, including use of objective (i.e., PSG and 
actigraphy) and subjective (i.e., sleep diary and self-report questionnaires) measures of sleep in adolescents 
101 
with T1DM. Given the paucity of research examining sleep in this population, additional research utilizing 
mixed-methods, including objective and subjective self-reports of various aspects of sleep quality and 
quantity, is necessary. Use of both objective and subjective sleep measures would also decrease shared 
variance associated with relying only on subjective self-reports of sleep quality and quantity.   
 To our knowledge, this is the first study to consider both caregiver- and adolescent-reported 
adolescent adherence to diabetes management tasks in relation to sleep in adolescents with T1DM. Given 
the paucity of research examining the relationship between sleep and adherence, additional research is 
needed to better understand the relationship between sleep and adherence. Future research should integrate 
additional measures of adherence, including both objective (i.e., data from CGM’s and insulin pumps) and 
subjective measures (e.g., frequency of blood glucose checks or 24-hour recall interviews).  
 As previously noted, another limitation of the current study is the discordant time frames used 
across measures of sleep quality, internalizing symptoms, executive functioning, adherence to diabetes 
management tasks, and most recent HbA1c. For example, the most recent HbA1c value represents glycemic 
control from up to 12 months before date of consent. Regarding sleep, adolescents were asked to report on 
sleep quality during the previous four weeks and daytime sleepiness during a “usual week” (Splisbury et 
al., 2007). Internalizing symptoms were assessed during the “past several months” (Reynolds & Kamphaus, 
2004) and difficulties with executive functioning were assessed during the previous 6 months (Gioia et al., 
2000). As such, the measurement time frame for constructs of interest may have limited to no overlap, 
which may have impacted results. The use of measures with similar timeframes may elucidate relationships 
among aspects of sleep quality, internalizing symptoms, neurocognitive functioning, and illness 
management in future research.  
 Generalizability of the present study may be limited due to issues associated with relative 
homogeneity of the sample (i.e., Caucasian, highly educated parents). Adolescents who consented but did 
not complete questionnaires had poorer metabolic control compared to adolescents who completed 
questionnaires. Therefore, the generalizability of the current findings to populations with greater diversity 
and poorer metabolic control may be limited. Future research should examine the relationships among 
variables of interest in more diverse samples with greater variability in racial, ethnic, and socioeconomic 
characteristics. Further, utilization of an age-matched control group without chronic illness would allow for 
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direct comparison of sleep parameters, internalizing symptoms, and executive functioning and help to 
highlight potential characteristics unique to adolescents with T1DM that may impact illness management.  
 Finally, several initially proposed analyses could not be performed. Analyses examining the 
relationship between aspects of adolescent sleep quality and metabolic control through anxiety, depression, 
and executive functioning were not performed due to limited bivariate correlations among variables of 
interest. Additionally, analyses examining the relationship between sleep quantity and T1DM-related 
outcomes through anxiety, depression, and executive functioning could not be performed due to limited 
sample size and power. Future research is needed to further clarify the complex relationships among sleep 
quality, quantity, and T1DM-related outcomes of interest through internalizing symptoms and executive 
functioning.   
Conclusion  
 The current study provides new insights into the relationships among adolescent sleep quality, 
daytime sleepiness, and disease management among adolescents with T1DM. Observed sleep quality and 
daytime sleepiness in the current sample are similar to the levels previously reported among healthy 
adolescents and are better than previously reported by adolescents with chronic pain conditions and 
depressive conditions. Poorer sleep quality, greater daytime sleepiness, and longer weekend sleep duration 
were found to be associated with poorer adherence to diabetes management tasks, but not metabolic 
control. Sleep quality was associated with illness management through anxiety, depression, and executive 
functioning. Additionally, daytime sleepiness was found to be associated with adherence through anxiety 
and has a direct effect on adherence independent of anxiety, depression, and executive functioning. 
Difficulties with anxiety and depression were found to be associated with adherence through daytime 
sleepiness, but not sleep quality. Given the paucity of research examining sleep in youth with T1DM, 
additional research is needed to better understand the interaction between T1DM disease processes and the 
bioregulatory mechanisms involved in sleep. Furthermore, additional research is needed to elucidate the 
relationship between sleep and illness management and outcomes among youth with T1DM. Results 
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